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INTRODUCTION 
Plants have been used for medicinal purposes long before recorded history. Ancient 
Chinese and Egyptian papyrus writings describe medicinal uses for plants as early as 3000 BC. 
Indigenous cultures such as African and Native American used herbs in their healing rituals, 
while other developed traditional medical systems such as Ayurveda and traditional Chinese 
medicine in which herbal therapies were used. 
The word “herb” has been derived from the Latin word, “herba” and an old French 
word “herbe”. 
Recently there has been a shift in universal trend from synthetic to herbal medicine, 
which we can say ‘Return to Nature’. Medicinal plants have been known for millennia and are 
highly esteemed all over the world as a rich source of therapeutic agents for the prevention of 
diseases and ailments. Nature has bestowed our country with an enormous wealth of medicinal 
plants; therefore India has often been referred to as the Medicinal Garden of the world. Countries 
with ancient civilizations such as China, India, South America, Egypt, etc. are still using several 
plant remedies for various conditions. In this regard India has a unique position in the world, 
where a number of recognized indigenous system of medicine viz., Ayurveda, Siddha, Unani, 
Homeopathy, Yoga and Naturopathy are being utilized for the health care of people. No doubts 
that the herbal drugs are popular among rural and urban community of India. The one reason for 
the popularity and acceptability is belief that all natural products are safe. The demand for plant 
based medicines, health products, pharmaceuticals, food supplement, cosmetics etc are 
increasing in both developing and developed countries, due to the growing recognition that the 
natural products are non-toxic, have less side effects and easily available at affordable prices. 
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Now a days, there is a revival of interest with herbal-based medicine due to the increasing 
realization of the health hazards associated with the indiscriminate use of modern medicine and 
the herbal drug industries is now very fast growing sector in the international market. But 
unfortunately, India has not done well in this international trade of herbal industry due to lack of 
scientific input in herbal drugs. So, it would be appropriate to highlight the market potential of 
herbal products and that would open floodgate for development of market potential in India. 
 
Historically herbal drugs were used as tinctures, poultices, powders and teas followed by 
formulations and lastly as pure compounds. Medicinal plants or their extracts have been used by 
humans since time immemorial for different ailment and have provided valuable drugs such as 
analgesics (morphine), antitussives (codeine), antihypertensives (reserpine), cardiotonics 
(digoxin), antineoplastics (vinblastine and taxol) and antimalarials (quinine and artemisinin).  
Some of the plants which continue to be used from mesopotamian civilization to this day are 
Cedrus spp., Cupressus sempervirens, Glycirrhiza glabra, Commiphora wightii and Papaver 
somniferum. About two dozen new drugs derived from natural sources were approved by the 
FDA and introduced to the market during the period 2000-2005 and includes drugs for cancer, 
neurological, cardiovascular, metabolic and immunological diseases and genetic disorders. 
Seven plant derived drugs currently used clinically for various types of cancers are taxol from 
Taxus species, vinblastine and vincristine from Catharanthus roseus, topotecan and irinotecan 
from Camptotheca accuminata and etoposide and teniposide from Podophyllum peltatum. It is 
estimated that the worldwide market potential for herbal drugs is around US$40 billion. Mostly 
herbal drugs are collected from the wild and relatively few species are cultivated. 
Overexploitation of plants, particularly when roots, tubers and bark are used for commercial 
purposes, has endangered 4,000 to 10,000 species of medicinal plants. To counter 
overexploitation of natural resources and the consequent threats to biodiversity, alternative 
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biotechnological methods and sustainable practices have been recommended. Several world 
organizations and governments have established guidelines for the collection and utilization of 
medicinal plants.   
TRADITIONAL USE OF MEDICINAL PLANTS 
 Traditional medicine is the sum total of the knowledge, skills and practices based on the 
theories, beliefs and experiences indigenous to different cultures used in the maintenance of the 
health, prevention of diseases and improvement of physical and mental illness. In practice, 
traditional medicine refers to the acupuncture (China), ayurveda (India), unani (Arabic 
countries), traditional birth attendant’s medicine, mental healer’s medicine, herbal medicine, and 
various forms of indigenous medicine.  
 Knowledge of the medicinal plants used in the drugs of traditional systems of medicine 
has been of great significance, especially as a lead for the discovery of new single- molecule 
medicines for modern system of medicine. To determine the chemical nature of such 
compounds, isolation of a substance in pure form using various separation techniques, chemical 
properties and spectral characteristics are a prerequisite for establishing its correct structure. 
Thus medicinal plants are used in crude or purified form in the preparation of drugs in different 
systems. Structural novelty and new modes of action are common features of plant drugs. This 
has been shown by anticancer agents like vinblastine, vincristine, and paclitaxel, cardiovascular 
agent like forskolin, anti-HIV agents like calanoid, and antihyperlipidemic agents like 
guggulsterones.       
WHY HERBAL MEDICINE? 
Herbal medicines are being used by about 80% of the world population primarily in the 
developing countries for primary health care. They have stood the test of time for their safety, 
efficacy, cultural acceptability and lesser side effects. The chemical constituents present in them 
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are a part of the physiological functions of living flora and hence they are believed to have better 
compatibility with the human body. Ancient literature also mentions herbal medicines for age-
related diseases namely memory loss, osteoporosis, diabetic wounds, immune and liver 
disorders, etc. for which no modern medicine or only palliative therapy is available. These drugs 
are made from renewable resources of raw materials by eco friendly processes and will bring 
economic prosperity to the masses growing these raw materials. 
 
ROLE OF WHO IN HERBAL MEDICINE 
Two decades ago, WHO referred to traditional health systems (including herbal 
medicine) as ‘holistic’ – ‘that of viewing man in his totality within a wide ecological spectrum, 
and of emphasizing the view that ill health or disease is brought about by an imbalance or 
disequilibrium of man in his total ecological system and not only by the causative agent and 
pathologenic evolution, probably implying that the indigenous system drugs (including herbal 
medicine) restore the imbalance or disequilibrium leading to the cure of ill health or disease. 
Such an attitude sent signals that WHO as an organization has failed to provide leadership to 
establish traditional systems of medicine which provide health care to about 80% of the world 
population. However, it helped the inclusion of proven traditional remedies in national drug 
policies and regulatory approvals by developing countries. The World Health Assembly 
continued the debate and adopted a resolution (WHA 42.43) in 1989 that herbal medicine is of 
great importance to the health of individuals and communities. Consequently, in 1991 WHO 
developed guidelines for the assessment of herbal medicine, and the same were ratified by the 
6th International Conference of Drug Regulatory Authorities held at Ottawa in the same year. 
The salient features of WHO guidelines are: (i) Quality assessment: Crude plant material; Plant 
preparation; Finished product. (ii) Stability: Shelf life. (iii) Safety assessment: Documentation of 
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safety based on experience or/and; Toxicology studies. (iv) Assessment of efficacy: Documented 
evidence of traditional use or/and; Activity determination (animals, human). 
 
EXPLORATION OF MEDICINAL PLANTS 
 Plants are a great source of therapeutic molecule. In the early 20th century, taxonomic 
surveys established the identity of plants, followed by ethnomedical surveys documenting the 
use of plants as medicine and other uses. The identification of active principles of medicinal 
plants leads to the use, misuse and abuse of substances of vegetable origin. The use may be 
curative (vincristine and vinblastine, reserpine, ephedrine, aspirin, morphine, digoxin) or narcotic 
abuse (cocaine, morphine and cannabis), and misuse has made several plants endangered species 
(e.g. Podophyllum hexandrum, Taxus baccata, Coptis teeta, Picrorhiza kurroa and Nardostachys 
jatamansi). This overexploitation has resulted in depletion in germplasm resources, particularly 
in third world countries, and urgently warrants the development of alternative biotechnological 
methods for micropropagation, the study of seed and reproductive biology. It is estimated that 
approximately 1500 plant species in india are threatened including 124 endangered species. 
About 2,50,000 species of higher plants are yet to be investigated for pharmacological activity. 
Plant can be a source of effective remedies for Alzheimer’s, parkinson’s, epilepsy, migraine, 
arthritis and schizophrenia. Increased demand for natural drug has led to the domestication of 
several plants such as Catharanthus roseus and Taxus baccata, and several others         (Psoralea 
corylifolia, Carthamus tinctorius) are being evaluated for agronomic traits. Improvements in 
isolation techniques to meet the demand for pharmacology, the generation of large of samples 
from correctly identified plants from the tropics for high-throughput screening, elaborate 
arrangements for preclinical (pharmacology, toxicology, pharmacokinetics and drug delivery) 
and clinical trials are required for drug development. 
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DEVELOPMENT IN HERBAL MEDICINE INDUSTRY WITH REFERENCE TO 
TRADE 
There is great demand for herbal medicine in the developed as well as developing 
countries like India, because of their wide biological activities, higher safety of margin than the 
synthetic drugs and lesser costs. Medicinal plants play a great role in food supplements for care 
as well as in personal care of the mankind alongside the therapeutically active substances, thus 
medicinal plant based industry is a promising sector and enormous economic growth potential. 
Nutraceuticals (Health Food) are in great demand in the developed world particularly USA and 
Japan. Nutraceutical market in USA alone is about $ 80-250 billion, with a similar market size in 
Europe and Japanese sales worth $ 1.5 billion. Such huge markets have arisen because of the 
Dietary Supplement Health Education Act passed by USA in 1994, which permits unprecedented 
claims to be made about food or the dietary supplements ability about health benefits including 
prevention and treatment of diseases. This act has motivated pharma to include not only 
compounds isolated from fauna and flora but also herbal medicines as Nutraceuticals, which is 
unfortunate. The Indian herbal pharma companies also see this as a good opportunity and are 
marketing such products. However, the importance of medicinal plants in the national economy 
and their potential for the rapid growth of herbal products, perfumery and allied industry in India 
has been emphasized from time to time. New trends are emerging in the standardization of 
herbal raw materials whereby it is carried out to reflect the total content of phytoconstituents like 
polyphenols, which can be correlated with biological activity. The major traditional sector 
pharmas, namely Himalaya, Zandu, Dabur, Hamdard, Maharishi, etc, are Standardizing their 
herbal Formulations by Chromatography techniques like TLC/ HPTLC finger printing, etc. 
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HERBAL MEDICINE STANDARDIZATION 
In indigenous/traditional systems of medicine, the drugs are primarily dispensed as water 
decoction or ethanolic extract. Fresh plant parts, juice or crude powder are a rarity rather than a 
rule. Thus medicinal plant parts should be authentic and free from harmful materials like 
pesticides, heavy metals, microbial or radioactive contamination, etc. The medicinal plant is 
subjected to a single solvent extraction once or repeatedly, or water decoction or as described in 
ancient texts. The extract should then be checked for indicated biological activity in 
experimental animal models. The bioactive extract should be standardized on the basis of active 
principle or major compounds along with fingerprints. The next important step is stabilization of 
the bioactive extract with a minimum shelf-life of over a year. The stabilized bioactive extract 
should undergo regulatory or limited safety studies in animals. Determination of the probable 
mode of action will explain the therapeutic profile. The safe and stable herbal extract may be 
marketed if its therapeutic use is well documented in indigenous systems of medicine, as also 
viewed by WHO. A limited clinical tribal to establish its therapeutic potential would promote 
clinical use. The herbal medicines developed in this mode should be dispensed as prescription 
drugs or even OTC products depending upon disease consideration and under no circumstances 
as health foods or nutraceuticals. 
 
CHAPTER-2 
 
LITERATURE REVIEW 
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                        LITERATURE REVIEW 
PLANT DESCRIPTION 
BOTANICAL CLASSIFICATION: 
Domain  : Eukaryota  
Kingdom  : Plantae 
Sub kingdom  : Viridiplantae  
Class   : Magnoliopsida 
Sub class  : Commelinidae 
Order   : Commelinales 
Division  : Magnoliophyta 
Super division  :           Spermatophyta 
Genus   : Commelina 
Species  : Benghalensis 
Family   :           Commelinaceae 
Botanical name : Commelina benghalensis L. 
Synonym  : Commelina mollis Jacq. 
    Commelina turbinata Vahl. 
Common name : Benghal dayflower, Tropical spiderwort, Wandering jew. 
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VERNACULAR NAMES 
Bengali                   :       Kanchira, Jata-kanshira, Dholapata 
English                   :       Day flower 
            Hindi                      :       Kanchara 
            Marathi                   :       Kena 
            Malayalam             :        Adukkavettila, Vuzhaipadathi, Vazhaplaachi, 
                                                     Kanavazhai 
             Sanskrit                  :       Kanchata 
             Tamil                      :       Kanangkarai, Kanavazhiain 
 
HABITAT AND DISTRIBUTION 
   Commelina benghalensis L. is a perennial herb native to tropical Asia and 
Africa. It is otherwise known as the paleotropics. Commelina benghalensis L. is often found in 
forest edges, road sides, cultivated fields, agricultural sites and home garden. 
DESCRIPTION 
 Herbs perennial, stems mostly creeping, ascending distally, diffuse, numerous 
branched, up to 70 cm, sparsely pubescent. Leaf sheaths sparsely hirsute-ciliate; petiole distinct; 
leaf blade ovate, 3–7 × 1.5–3.5 cm, subglabrous. Involucral bracts borne opposite leaves, often 
several, aggregated at apex of branches, very shortly stalked, funnelform, 0.8–1.2 cm, sparsely 
hairy, proximal margins connate, apex acute or obtuse. Proximal branch of cincinni with 
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elongate peduncle and 1–3 exserted, infertile flowers, distal branch longer, with several fertile 
flowers. Sepals calyx 2 mm, membranous. Petals blue, 3–5 mm. Capsule ellipsoid, 4–6 mm, 3-
valved; posterior valve 1-seeded or seedless, indehiscent; other 2 valves each 2-seeded, 
dehiscent. Seeds black, cylindric or semicylindric, ca. 2 mm, rugose, irregularly reticulate, 
truncate at 1 end. Fl. summer to autumn.  
Wet places; near sea level up to 2300m. Anhui, Fujian, Guangdong, Guangxi, Guizhou, 
Hainan, Hebei, Henan, Hubei, Hunan, Jiangsu, Jiangxi, Shaanxi, Shandong, Sichuan, Taiwan, 
Yunnan, Zhejiang (tropical and subtropical Africa and Asia).  
FLOWER 
Cleistogamous flowers are formed in the smaller, funnel form involucral bracts on slender 
and creeping branches, which possess bladeless leaf sheaths and arise from the base of the plants. 
Flowers blue colour. 
FRUITS (Capsule)  
Capsules produced by such flowers are at the soil surface or in the soil, but only 1 or 2 valves 
are developed, each containing 1 or 2 seeds, which are larger than normal.  
      In all districts except in the wettest localities; Sea-level to 4000 ft. The lower nodes 
sometimes develop naked underground shoots bearing smaller white flowers which ripen large 
seeds underground, whereas perfect seeds are often not developed in the normal flowers. 
(Gamble JS and Fischer CEC, 1967: Hong Deyuan and Robert A. DeFilipps, 2000). 
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ETHNOCLAIM USES 
LEAVES 
 Sandhya B et al., 2006, had investigated this plant  used by Valaiyans an ethnic group 
residing in and around Piranmalai hills, Tamilnadu in combination with Jasminum angustifolium 
leaf used for the treatment of rabies. 
Mahabub Nawaz AH Md et al., 2009, had surveyed ethnobotanical information of  
traditional healers of Rajshahi district, Bangladesh, using paste of young leaves mixed with lime 
and a little amount of salt and massaged on the affected area twice daily in the morning and 
evening for external poisoning. 
 Gupta A et al., 2010, had investigated ethnopotential of medicinal herb is used for skin 
diseases is used to treat wounds.   
LEAF AND ROOT 
 Mohammed Rahmatullah et al., 2012, had surveyed this medicinal plant formulation of 
Kavirajes Faridpur and Rajbari districs, Bangladesh. Leaves of Commelina benghalensis L. are 
macerated with rhizomes of Zingiber officinale and applied to the hooves of cattle at the same 
time roots of Commelina benghalensis L. are tied around the throat of cattle for foot and mouth 
diseases in cattle. 
WHOLE PLANT 
 Nadkarni K M, 1926, had reported the whole plant used as a demulcent, refrigerant, and 
laxative. 
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Lewu F B and Afolayan A J, 2009, had studied ethno medicinal importance of weedy 
species growing in SouthAfrica. They reported Commelina benghalensis L. traditionally used to 
treat infertility.  
Mohammed Rahmatullah et al., 2010, had surveyed medicinal plant used by folk 
medicinal practitioners in ten districts of Bangladesh to treat leprosy.  
 Chaitanya et al., 2013, had reported ethnomedicinal uses of weedy species in Nilgiris, 
Tamilnadu. The Badagas of Nilgiris used this plant decoction internally to cure worm infection.  
 Kumar P et al., 2013, had studied medicinal floristic wealth at Aravalli Hills range in 
Khanak (Haryana), India. They reported Commelina benghalensis L. used for the treatment of 
burn, skin diseases and conjunctivitis. 
Raphael Ranjit Marandi and John Britto S, 2015, had studied medicinal properties of 
edible weeds of crop fields and wild plants eaten by Oraon Tribals of Latehar District, 
Jharkhand. They reported that Commelina benghalensis L. young plant is cooked as a vegetables 
and used as a emollient, laxative, and demulcent. They also used for the treatment of leprosy, 
suppurative sores, snake bite, swelling, burns, antioxidant, cancer, ulcer, and skin diseases.  
FLOWER 
 Jimmy Okello and Paul Ssegawa, 2007, had surveyed medicinal plants used by 
communities of Ngai subcounty, Apac district, Northen Uganda. Flowers are squeezed into the 
nose for the treatment of nasal blockade in children. 
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STEM 
 Muniappan Ayyanar and Savarimuthu Ignacimuthu, 2011, had surveyed this plants 
commonly used by Kani tribals of Tirunelveli hills of Western Ghats, India. They reported stem 
juice is topically applied for the treatment of wounds. 
ROOT 
 Bhaskar VV and Patil HM, 2005, had reported tribals of Nandurbar district in 
Maharashtra, India using root powder admixed with equal amount of jaggary for the treatment of 
epilepsy.  
Arshad Mehmood Abbasi et al., 2013, had surveyed ethnobotanical appraisal and cultural 
values of medicinally important wild edible vegetables of lesser Himalayas-Pakistan. Dried roots 
of Commelina benghalensis L. grinded and powder is taken orally for epileps  
Sheila Maregesi M et al., 2016, had studied plants traditionally used for the treatment of 
eye diseases in Kigoma district, Tanzania. They reported Commelina benghalensis L. sap  and 
root decoction is warmed with camphor used as eye drops for eye ailments and conjuctivities. 
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PHYTOCHEMICAL REVIEW 
LEAVES  
Udaya Prakash NK et al., 2011, had studied phytochemical analysis of aqueous extract of 
Commelina benghalensis L. showed the presence of tannins, phlobatannins, saponins, flavonoids 
and absence of terpenoids, cardiac glycosides and steroids. 
Bodke SS et al, 2012, had studied preliminary phytochemical analysis of weeds in 
Marathwada region. They reported Commelina benghalensis L. showed the presence of 
alkaloids, tannins, saponins, steroids and flavonoids.   
Bibin Baby Augustine et al., 2013, had reported preliminary phytochemical analysis of 
hydroalcoholic extract of Commelina benghalensis L. It showed the presence of alkaloids, 
flavonoids, tannins, carbohydrates and saponins. 
Prayaga Murty P et al., 2013, had studied preliminary phytochemical screening of some 
weed species of Kadapa district, Andhra Pradesh, India. Commelina benghalensis L. showed the 
presence of alkaloids, saponins, tannins, steroid and flavonoids. 
Kharade Amit S et al., 2013, had reported preliminary phytochemical investigation of 
Aqueous and Alcoholic extracts of Commelina benghalensis L. It showed the presence of 
alkaloids, carbohydrates, phytosterol, flavonoids, terpenoids, quinon and tannins. 
 Udaya Prakash NK et al, 2013, had studied phytochemical analysis of aqueous extract of 
Commelina benghalensis L. showed the presence of phlobatannins and saponins. 
Chichioco Hernandez et al., 2014, had studied phytochemical analysis of methanolic 
extract of Commelina benghalensis L. showed the presence of terpenoids and flavonoids. 
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Krishna Satya A et al., 2016, had evaluated qualitative phytochemical analysis of 
chloroform and aqueous extracts of Commelina benghalensis L. Chloroform extract showed the 
presence of alkaloids, flavonoids, tannins and absence of phenol, terpenoids, saponins. Aqueous 
extract showed the presence of alkaloids, tannins and absence of phenol, flavonoids, terpenoids, 
saponins. 
Sumithra D and Sumithra Purushothaman, 2017, had studied phytochemical profiling of 
ethanolic extract of commelina benghalensis L. by using Gas chromatography-Mass 
spectrometry (GC-MS). GC-MS analysis of commelina benghalensis L. revealed the presence of 
bioactive compounds such as 3-dodecene, 1-hexadeconol, 9-eicosene and tetratriacontane, 
Phenol 2,4 bis(1,1 dimethyl ethyl), hexadecen1 ol trans9,  9,10 anthracenedione, tetracosane, 1,4 
benzene-dicarboxylic acid, bis (2ethylhexyl) ester, 13 docosenamide, tetracosane 11 decyl.
  
 Sumithra.D and Sumithra Purushothaman, 2017, had investigated phytochemical 
screening of different (acetone, ethanol and water) extract of Comelina benghalnsis L. Aqueous 
extract showed the presence of carbohydrate, phlobatannins, flavonoid, saponin, tannin, volatile 
oil. Ethanol extract showed the presence of carbohydrate, phlobatannins, alkaloid, flavonoid, 
saponin, tannin, volatile oil, anthraquinone. Acetone extract showed the presence of 
carbohydrate, phlobatannins, alkaloid, flavonoid, saponin, volatile oil, anthraquinone. 
LEAVES & STEMS 
 Sharmila Banu Ghani et al., 2016, had studied preliminary phytochemical screening of 
different extracts with solvents such as (aqueous, methanol, hexane, and carbontetrachloride) of 
Commelina benghalensis L. It showed the presence of phytochemical constituents such as 
alkaloids, protein,  aminoacids, flavonoids, saponins, total phenols,and tannins and absence of 
anthraquinones, glycosides, steroids, and triterpenoids. 
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WHOLE PLANT 
 Armando et al., 2010, had evaluated preliminary phytochemical analysis of aqueous and 
alcoholic extracts of Commelina benghalensis L. It showed the presence of alkaloids, lactones, 
coumarins, triterpenes, steroids, resins, reducing agent, phenols, tannins, aminoacids, quinones, 
flavonoids and saponins.  
Ibrahim et al., 2010, had performed thin layer chromatography and phytochemical 
analysis of Commelina benghalensis L. The phytochemical screening revealed the presence of 
phlobatannins, carbohydrates, tannins, glycosides, volatile oils, resins, balsams, flavonoids and 
saponins while terpenes, sterols, anthroquinones and phenols were absent. Thinlayer 
chromatography development revealed three spots for hexane extract, six spots for ethylacetate 
and five spots for methanol. 
 Ndam LM et al, 2014, had studied phytochemical screening of the bioactive compounds 
in twenty Cameroonian medicinal plants. They reported acetone extract of Commelina 
benghalensis L. showed the presence of steroids and flavonoids.    
Balakrishnan CP and Jenifer Panneer, 2015, had studied phytochemical analysis of 
different extracts (Benzene, petroleum ether, chloroform, acetone, methanol, water) of 
Commelina benghalensis L. It showed the presence of bioactive compounds such as alkaloids, 
catechin, flavonoids, phenol, quinones, saponins, tannins, sugar, glycosides, protein, and 
aminoacids were present. Anthraquinone, coumarin, and xanthoprotein were absent. 
 Gurjar Himanshu PS et al., 2016, had studied preliminary phytochemical investigation of 
methanolic extraction of Commelina benghalensis L. It revealed the presence of different types 
of chemical constituents such as stigmasterol, alkaloids, carbohydrate, glycosides, flavonoids, 
aminoacids, and phenolic compounds. 
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Kaliyamoorthy Jayakumar, 2016, had investigated phytochemical screening of alcoholic 
extract of Commelina benghalensis L. It showed the presence of carbohydrate, phytosterols, 
alkaloids, flavonoids, and terpenoids, quinone, tannins. 
TUBERS 
 Sharad Srivastava et al., 2016, had studied simultaneous reverse - phase HPLC 
determination of major antioxidant phenolics in methanolic extract of Commelina benghalensis 
L. Reverse – phase high performance liquid chromatography – photodiode array detection (RP-
HPLC-PDA) method was developed for the separation, identification and quantification of 
bioactive phenolics. In this method five phenolics protocatechuic acid (0.033%), vanillic acid 
(0.262%), ferulic acid (0.365%), apigenin (0.126%) and kaempferol (0.544%) were quantified in 
linearity range of 0.2-1.0 µg with correlation coefficient of more than 0.9949. Antioxidant 
activity was determined by DPPH Radical scavenging activity. The methanolic extract shows the 
inhibition range from 24.45 to 68.75% at 0.02-0.12 mg Ml-1 in comparison with standard 
ascorbic acid, quercetin and rutin. 
 
 
 
 
 
 
 
 
                                                                                       LITERATURE REVIEW 
 
DEPT.OF PHARMACOGNOSY, COP, MMC, MADURAI-20 Page 18 
 
PHARMACOLOGICAL REVIEW 
LEAVES 
ANTIMICROBIAL ACTIVITY 
 Mukesh Chandra Sharma and Smita Sharma, 2010, had investigated antimicrobial 
activity of different (aqueous, hexane, chloroform, methanol) extracts of Ixora coccinea L. and 
Commelina benghalensis L. on Gram-Positive and Gram-Negative microorganism by agar well 
diffusion method. The extract concentration of 100% exhibit high antimicrobial activity against 
E.coli with modest activity against S.typhi, S.aureaus. Methanol extract showed broad spectrum 
activity in comparision with amoxicillin and gatifloxcin. 
ANTIMICROBIAL ACTIVITY 
 Gothandam KM et al., 2010, had studied antimicrobial properties of methanolic extract 
of few medicinal plants by disc diffusion method. Commelina benghalensis L. showed the 
antimicrobial activity against Gram positive and Gram negative organism. 
ANTIBACTERIAL ACTIVITY 
 Rajesh F. Udgirkar et al., 2012, had reported aqueous extract of  Commelina 
benghalensis L. possessing antibacterial activity determined by agar diffusion method. 
ANTI – INFLAMMATORY ACTIVITY 
 Bibin Baby Augustine et al., 2013, had reported anti-inflammatory and toxicity effect 
evaluation of hydroethanolic extract of Commelina benghalensis L. on female rats. 
Hydroethanolic extracts of Commelina benghalensis L. did not show any toxic reaction in female 
rats in acute and subacute toxicity test at a dose level of 200 and 400 mg/kg. Anti-inflammatory 
activity was studied by using carrageenan induced rat paw edema, cotton pellet granuloma and 
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xylene induced ear edema model at two different doses (200 and 400 mg/kg b.w). 
Hydroethanolic extract of Commelina benghalensis L. exhibited significant Anti-Inflammatory 
activity in carrageenan induced rat paw edema, at a dose level of 400 mg/kg. cotton pellet 
granuloma and xylene induced ear edema model at a dose level of 200 and 400 mg/kg of 
bodyweight shows significant Anti-inflammatory activity as compared to the control group with  
indomethacin.  
ANTIPLASMODIAL ACTIVITY 
 Ngo Bum E, Ngo Yebga J, Njan Nloga AM, 2014, had studied antiplasmodial effect of 
aqueous leaf extract of Commelina benghalensis L. and bark of Steganotaenia araliacea on the 
Human populationin Ngaoundere (Cameroon). The combination of Commelina benghalensis L. 
and Steganotaenia araliacea extract mixture was given to patient for ten days. Antiplasmodial 
effect was assessed by frequencies and the parasites densities of plasmodium species. Treatment 
of patient with mixture of the extracts revealed a progressive reduction of infestation up to a total 
dispiriting of the parasites after ten days and shows significant antiplasmodial activity in 
comparision with Amodiaquine.    
15-LIPOOXYGENASE INHIBITION ACTIVITY 
Chichioco Hernandez et al., 2014, had evaluated 15-Lipooxygenase inhibition of 
methanolic extract of Commelina benghalensis L., Tradescantia fluminensis, and Tradescantia 
zebrina by 15-Lipooxygenase inhibitory assay. The inhibitory activity was evaluated by using a 
spectrophotometric assay by observing the increase in absorbance at 234 nm due to the 
formation of the product 13 – hydro peroxy octadecadienoic acid. All the methanolic extracts 
significantly inhibited the action of 15 – lipooxygenase at a concentration of 0.2 µg/ml.   
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THROMBOLYTIC AND CYTOTOXIC ACTIVITY 
 Abul Hasanat et al., 2015, had investigated thrombolytic  and cytotoxic activity of 
methanolic extract of Commelina benghalensis L. The cytotoxicity had been assessed by Brine 
shrimp lethality bioassay and also thrombolytic activity had been assessed by thrombolytic 
impact with individual blood. The Brine shrimp lethality bioassay result was (LC50 = 278.69 
µg/ml) compared with standard vincristine sulphate ( LC50 = 0.512 µg/ml). It has significant 
thrombolytic activity (40.94%) compared with standard streptokinase (75%). 
ANTIBACTERIAL ACTIVITY 
 Joy Prabhu H and Johnson I, 2015, had investigated antibacterial activity of silver 
nanoparticles synthesized from aqueous extract of Commelina benghalensis L. by disc diffusion 
method. The antimicrobial activity of silver nanoparticles was investigated against escherichia 
coli, klebsiella pneumonia, vibrio cholorae, salmonella typhi, and shigella sonnei by disc 
diffusion method. These results suggest that silver nanoparticles can be used as effective growth 
inhibitor in various microorganism, making them applicable to diverse medical system and 
antimicrobial control system. 
ANTIDIARRHOEAL AND ANTHELMINTIC ACTIVITY 
 Mohammad Mamun Ur Rashid et al., 2016, had studied antidiarrhoeal and anthelmintic 
activity on methanolic extract of Commelina benghalensis L. Antidiarrhoeal activity was studied 
by invivo method such as castor oil induced diarrhea, castor oil induced enteropooling and 
gastrointestinal motility test in Swiss albino mice. Methanol extract at 200 and 400 mg/kg 
exhibited significant dose dependent antidiarrhoeal activity in comparision with standard drug 
loperamide. Anthelmintic activity was determined by invitro anthelmintic assay in aquarium 
worm Tubifex tubifex. Methanol extract showed dose dependent Anthelmintic activity when 
compared with Levamisole used as standard. 
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ANTICOAGULANT ACTIVITY 
 Krishna Satya A et al., 2016, had studied efficacy of medicinal plants against the lethality 
of Naja Naja snake envenomation. Inhibiting property of (toxic) lethal factors like PLA2, 
coagulant activity, proteolytic activity and aceylcholine esterase activity of venom were studied. 
Aqueous extract of Commelina benghalensis L. inhibits the serum coagulation of the venom. 
Aqueous extract of Commelina benghalensis L. in  PLA2 activity inhibition is 59%. The 
coagulant factors in the venom of Naja Naja were inhibited by aqueous extract of Commelina 
benghalensis L. 
. ANTIBACTERIAL ACTIVITY 
 Sumithra D and Dr. Sumithra Purushothaman, 2017, had investigated antibacterial 
activity of different (acetone, ethanol, water) extracts of Commelina benghalensis L. by agar well 
diffusion method. It showed the antibacterial activity against escherichia coli, bacillus subtilis, 
staphylococcus aureus, enterococcus faecalis while no inhibitory activity against klepseilla 
pneumonia. 
AERIAL PART 
SEDATIVE AND ANXIOLYTIC ACTIVITY 
Shafiqur Rahman et al., 2009, had investigated different soluble fraction ( chloroform, 
petroleum ether, n-butanol, hydromethanol ) of the Commelina benghalensis L. showed Sedative 
and Anxiolytic properties. Sedative property was determined by Rodent behavioural model such 
as hole cross, open field and Thiopental sodium induced sleeping time in mice. chloroform and 
petroleum ether fraction showed significant dose dependent sedative activity in comparision with 
Diazepam. Anxiolytic property was determined by elevated plus-maze (EPM) Test in mice. 
chloroform and petroleum ether fraction showed significant dose dependent anxiolytic activity in 
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comparision with diazepam. Hydromethanol and n-butanol fraction are not found to be 
statistically significant.   
ANALGESIC ACTIVITY 
Mazumder MEH et al., 2010, had evaluated different fraction (petroleum ether, 
chloroform, n-butanol, hydromethanol) of the Commelina benghalensis L. extracts exhibited 
Analgesic activity. Peripherally acting analgesic activity was determined by Aceticacid-induced 
writhing test in mice. The different fraction of extract showed significant dose dependent 
analgesic activity in comparison with diclofenac sodium. Centrally acting analgesic activity was 
determined by hot plate and tail immersion method in mice. The different fraction of extract 
exhibited significant analgesic activity in comparison with standard drug Nalbuphine. All 
fraction at the dose of 200 and 400 mg/kg of bodyweight showed significant analgesic action in a 
dose dependent manner in the tested models. 
ANTIOXIDANT ACTIVITY 
 Anusuya et al., 2012,  had evaluated antioxidant and free radical scavenging effect of 
different extracts (Acetone, Methanol, Water) of Commelina benghalensis L. by various invitro 
assays. All the extracts contained considerable levels of total phenolics, tannins, flavonoids, and 
vitamin c content and also exhibited increasing reducing activity with increasing concentration. 
ANXIOLYTIC ACTIVITY 
 Madhuri D. Bhujbal et al., 2012, had reported anxiolytic properties of the four different 
soluble fraction (chloroform, petroleum ether, n-butanol, hydromethanol) of the Commelina 
benghalensis L. by rodent behavioural model. maximum effect was shown by chloroform and 
petroleum ether fraction compared to the reference standard Diazepam. chloroform and 
petroleum ether soluble fraction has significant anxiolytic effect. 
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ANTIOXIDANT ACTIVITY 
Nizam Uddin et al., 2013, had studied DPPH scavenging assay of eighty four 
Bangladeshi medicinal plants. Chloroform, petroleum ether, n-butanol, hydromethanol extracts 
of Commelina benghalensis L. are assayed by DPPH scavenging assay. It showed excellent 
DPPH scavenging property (90% or more) in comparision with ascorbic acid and BHT 
(Butylated Hydroxy Toluene). petroleum ether fraction shows good scavenging property. 
CYTOTOXIC ACTIVITY 
Amina Khatun et al., 2014, had studied cytotoxicity potential of methanolic extract of 
Commelina benghalensis L. by brine shrimp lethality bioassay. It showed the quite high 
cytotoxicity LC50 ranging from 21 to 115 µg/mL. 
WHOLE PLANT 
ANTIBACTERIAL ACTIVITY 
 Parekh J and Chanda S, 2007, had studied invitro screening of antibacterial activity of 
aqueous and alcoholic extracts of Commelina benghalensis L. against selected pathogens from 
enterobacteriaceae. Antibacterial assay was performed by agar disc diffusion method for aqueous 
extract and agar well diffusion method for alcoholic extract. It showed the zone of inhibition in 
Klebsiella pneumoniae.   
ANTIMICROBIAL  ACTIVITY 
 Armando et al., 2010, had reported antimicrobial evaluation of aqueous and ethanolic 
extract of Commelina benghalensis L. by Agar well diffusion method. Antimicrobial assay was 
performed on staphylococcus aureus, candida albicans (isolated from patient), and Escherichia 
coli. Gentamycin for the bacteria and Nystatin for the fungai were used as a control antibiotics. 
The ethanol extract are superior in performance compared to the aqueous extract. In both 
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ethanolic extract activity against candida albicans > escherichia coli > staphylococcus aureus. 
Aqueous extract showed virtually no activity against the staphylococcus aureus, escherichia coli 
and candida albicans strains.  
ANTIBACTERIAL ACTIVITY 
 Mohammad AA Khan et al., 2011, had studied antibacterial activity of different extracts 
(Ethanolic, Petroleum etheric, Diethyl etheric, Methanolic, Aqueous) of Commelina 
benghalensis L. by Agar disc diffusion method. Minimum inhibitory concentration was 
determined by micro dilution method. Antimicrobial activity of the extracts at two different 
concentration of 250 and 500 µl/discs were compared with those of positive control such as 
Azithromycin and Tetracycline at the dose of 30 µg/disc. The extract possess maximum potency 
against infectious pathogens such as staphylococcus saprophyticus, staphylococcus aureus, 
enterococcus faecalis, staphylococcus pyogenes, streptococcus agalactiae, salmonella typhi, 
Escherichia coli, shigella boydii, shigella dysenteriae and pseudomonas aeruginosa. It showed 
significant minimum inhibitory concentration. 
NEPHROPROTECTIVE ACTIVITY 
 Kokilavani.P, Achiraman.S, Pandilakshmi.P, 2015, had investigated protective and 
curative effect of Aqueous extract of Commelina benghalensis L. and Cissus quadrangularis 
against quinalphos induced oxidative stress in swiss albino mice kidney tissue. Raising the level 
of serum urea, uric acid, and creatinine confirmed the nephrotoxicity induced by quinalphos. 
Significant increasing of creatinine level indicate the kidney damage. Protective effect of 
nephrotic damage was determined by serum biochemical analysis and histomorphological 
analysis of kidney.Cissus quadrangularis showed better protection compared to the Commelina 
benghalensis L. Commelina benghalensis L. and Cissus quadrangularis aqueous extract showed 
significante protection of  nephrotic cell damage from oxidative stress caused by quinalphos. 
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ANTIDIABETIC ACTIVITY 
 Gurjar Himanshu PS et al., 2016, had studied antidiabetic activity of methanolic extract 
of Commelina benghalensis L. in male albino rat by Alloxan induced diabetes mellitus model. 
The methanolic exract of Commelina benghalensis L. ( 100,200,400 mg/kg i.p) has showed  
significant Antidiabetic activity in Alloxan induced diabetic rat in comparison with 
glibenclamide. It also significantly reduces the elevated level of blood cholesterol and 
triglyceride. The extract significantly improved the Alloxan induced reduction of blood protein 
to normal value.   
ANTINOCICEPTIVE ACTIVITY 
 Mohammad Shah Hafez Kabir et al., 2016, had investigated antinociceptive action of 
methanolic extract of Commelina benghalensis L. in mice by aceticacid-induced writhing test 
and formalin induced licking test. The methanolic extract exhibited significant dose dependent 
antinociceptive  activity in comparision with diclofenac sodium. 
STEM 
ANTICANCER ACTIVITY 
 Leseilane J.Mampuru et al., 2008,  had Investigated Alteration of Bax-to-Bcl-2 ratio 
modulates the anticancer activity of methanolic extract of Commelina benghalensis L. in Jurkat 
T cells. Jurkat T cells were exposed to different concentration (0 – 600 µg/ml) of the crude 
methanolic extract of Commelina benghalensis L. to evaluate their growth inhibitory and 
apoptosis inducing effects. The extract elicited a dose and time dependent inhibition of cell 
proliferation, followed by a concomitant decrease in cell viability. The observed cytotoxicity was 
linked to the induction of apoptosis as determined by morphological and biochemical features 
known to be associated with the advent of apoptosis.  Real time quantitative RT-PCR analysis of 
apoptosis regulatory genes and western blot analyses of Bax, Bcl-2 and p53 exhibited aberrant 
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expression profiles of these genes under various treatment condition. They reported crude 
methanolic extract of Commelina benghalensis L. contains bioactive compounds that may be 
beneficial in the treatment of malignant growths, and that this antineoplastic activity is a 
consequence of dysregulated expression of apoptosis responsive genes.   
 Matlou Phineas Mokgotho et al, 2014, had evaluated subfraction (n-hexane (F1) and 
dichloromethane (F2)) of acetone extracts of Commelina benghalensis L. induced apoptosis and 
cell cycle arrest in jurkat T cells. After treatment of Jurkat T cells with these subfractions, cell 
proliferation, viability, and apoptosis were determined by using a haemocytometer, the trypan 
blue dye exclusion assay, and Hoechst 33258 staining respectively. Cell division cycle 
distribution profile were analysed using an Epics alba flow cytometer and the expression of cell 
division cycle regulatory genes was analysed  using RT-PCR, while immuno reactive proteins 
were detected on western blots. The F1 and F2 fraction inhibited the proliferation and viability of 
jurkat T cells in a concentration and time dependent manner. Both fractions induced a G1/S 
interphase arrest of the cell division cycle of jurkat T cells.   
WOUND HEALING ACTIVITY 
 Gulzar Alam et al., 2011, had reported Commelina benghalensis L. juice is applied for 
healing of wounds.  
ROOT 
HEPATOPROTECTIVE ACTIVITY 
 Sambrekar SN et al., 2009, had studied hepatoprotective activity of various root extracts 
of Commelina benghalensis L. by paracetamol induced liver damage model in Wistar rats. Liver 
damage was produced by paracetamol. Aqueous as well as alcoholic extract showed significant 
hepatoprotective activity and efficacy of alcoholic extract was almost comparable to that of N-
Acetyl 1-Cystine. 
                                                                                       LITERATURE REVIEW 
 
DEPT.OF PHARMACOGNOSY, COP, MMC, MADURAI-20 Page 27 
 
 Sambrekar Sudhir N, Patil Suhas A et al., 2013, had investigated alcoholic and aqueous 
extract of Commelina benghalensis L. on ethanol induced acute hepatotoxicity in male wistar 
rats showed possible mechanism and hepatoprotective effect. Hepatoprotective effect was 
determined by invivo hepatotoxic parameter including serum transaminase (AST and ALT), 
ALP, bilirubin, protein, lipid profile (cholesterol, triglyceride, VLDL and HDL) and level of 
antioxidant together with histopathological examination. Liv52 was used as a reference 
hepatoprotective agent. Phenobarbitone induced sleeping time study was carried out to verify the 
effect on microsomal enzymes. Histopathological observation confirmed the beneficial roles of 
MF against Ethanol induced liver injury in rats. Possible mechanism may involve their 
antioxidant activity.  
ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY 
 Sanjib Saha et al., 2014, had evaluated ethanolic extract of Commelina benghalensis L. 
showed Analgesic and Anti-inflammatory activity. Peripherally acting analgesic activity was 
determined by Acetic acid induced writhing test in swiss albino mice and centrally acting 
analgesic activity was determined by hot plate and tail flick test in mice. In aceticacid induced 
writhing test it showed significant analgesic activity in comparision with diclofenac sodium. In 
Hotplate and Tail flick test it showed significant analgesic activity in comparision with 
Morphine. Anti-inflammatory activity was determined by carrageenan induced paw edema in 
mice. The ethanol extract exhibited significant dose dependent anti-inflammatory activity in 
comparision with Indomethacin.  
 INFLORESCENCE 
 Baljinder Singh et al., 2011, had reported Commelina benghalensis L. used for eye 
diseases. 
CHAPTER-3 
 
AIM AND OBJECTIVE 
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AIM AND OBJECTIVES 
AIM 
 The aim of present research is to investigate the Pharmacognostical, 
Phytochemical studies including Isolation of Lutein and its Sun Protection Factor, Invitro 
Anti-Inflammatory, Anti-Arthritic and Anti-oxidant activity of Commelina benghalensis 
L. (Commelinaceae). 
OBJECTIVE 
 The present work has been planned to carry out the 
PHARMACOGNOSTICAL STUDIES 
 Authentification and collection of plant 
 Macroscopy of the leaf 
 Microscopy of the leaf 
 Powder microscopy includes its identification of  character 
 Behavioural characters with different reagents 
Physiochemical Parameters 
 Foreign matter 
 Loss on drying (LOD) 
 Extractive value with various reagent 
 Ash values 
 Total solids 
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PHYTOCHEMICAL STUDIES  
 Preparation of Hydroalcohol Extract 
 Qualitative analysis   
 Preliminary Phytochemical Screening 
 Identification of Rf  value by TLC method 
 
 Quantitative Estimation of Phytoconstituents 
 Tannic acid 
 Gallic acid 
 Rutin in terms of its equivalents 
 Determination of Chlorophyll “a”, Chlorophyll “b”, Total chlorophyll and Total 
carotenoids. 
ISOLATION OF LUTEIN  
PHARMACOLOGICAL STUDIES  
 Determination of Sun Protection Factor of Isolated Lutein From Commelina 
benghalensis L. 
 Invitro Anti-Inflammatory Activity Screening By Membrane Stabilization Study 
 Invitro Antiarthritic Activity By Protein Denaturation Method 
 In vitro Antioxidant Activity 
 Hydrogen peroxide scavenging activity 
 Reducing power assay 
 Total antioxidant activity 
 
  
CHAPTER-4 
 
MATERIALS AND METHODS 
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MATERIALS AND METHODS 
PLANT COLLECTION & AUTHENTIFICATION 
Fresh leaf of Commelina benghalensis L. were collected from  Madurai Medical College, 
Madurai (DT), during the month of August- 2017 and was  authenticated by Dr. D. Stephen, 
M.Sc., Ph.D., Assistant professor, Department of Botany, American College,  Madurai-20. The 
herbarium of this specimen was kept in the department for further reference. 
PART A 
PHARMACOGNOSTICAL STUDIES 
 Morphological and micro morphological examination and characterization of medicinal 
plants have always been accorded due credentials in the pharmacognostical studies. Botanical 
identity of the plants is an essential prerequisite for undertaking the analysis of medicinal 
properties of any plant. A researcher may succeed in getting a new compound or may find many 
useful pharmacological active properties in the plant. If the botanical identity of the plant 
happens to be dubious or erratic, the entire work on the plant becomes invalid. Thus it is needless 
to stress the botanical identity of the crude drug is the threshold in the processes of 
pharmacological investigations. The researchers should be equipped with all possible diagnostic 
parameters of the plant on which the researchers plan to work. 
MORPHOLOGICAL STUDIES OF Commelina benghalensis L. 
            Leaves were studied seperately for its morphological characters by organoleptic test. 
 
MICROSCOPICAL STUDIES OF Commelina benghalensis L. 
     Fresh leaves were selected for the microscopical parameters  by using microscope. 
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COLLECTION OF SPECIMEN 
Care was taken to select healthy plants and for normal organs. Leaf, Petiole specimens 
were collected from a healthy plant by making a cut with petioles. The materials were cut into 
pieces and immediately immersed in fixative fluid FAA (Formalin – 5ml + Acetic acid – 5ml 
+70% Ethyl alcohol – 90ml).  
DEHYDRATION 
After 24 hours of fixing, the specimens were dehydrated with graded series of  ethyl 
alcohol and tertiary-butyl alcohol (Sass, 1940). The specimen is kept is in each grade of the fluid 
for about 6 hrs. Every time the fluid is decanted and immediately the specimen were flooded 
with next grade of fluid.  
INFILTRATION WITH PARAFFIN WAX 
After dehydration, the shavings of paraffin wax were added to the vial containing the plant 
material with pure TBA. The paraffin shavings are added every 30mts at about 40-45ºC four or 
five times. Then the vials were filled with wax without damaging the tissues. The vial filled with 
wax is kept open in warm condition to evaporate all TBA, leaving the specimen in pure molten 
wax. The specimen filled with pure molten wax for 2 or 3 times by decanting the old wax every 
time. 
CASTING TO MOLD 
A boat made out of chart board, by folding the margin, is used to prepare a mold of wax 
containing specimens. The paraffin along with the leaf and petiole specimen was poured into the 
boat. With the help of heated needles, the specimen were arranged  in parallel rows with enough 
space in between the specimens. The block was then immersed in chilled water and allowed to 
cool for few hours. 
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SECTIONING 
The paraffin embedded specimens were sectioned with the help of microtome. The 
thickness of the sections was 10-12ȝm. Dewaxing of the sections was by customary procedure. 
The sections were stained with Toluidine blue as per the method published by O’Brien et al 
(1964). Since toluidine blue is a poly chromatic strain, the straining results were remarkably 
good and some cytochemical reactions were also obtained. The dye rendered pink colour to the 
cellulose walls, blue to the lignified cells, dark green to suberin, violet to the mucilage, blue to 
the protein bodies etc. Where ever necessary sections were also stained with safranin and fast-
green and potassium iodide (for starch). For studying the stomatal morphology, venation patttern 
and trichome distribution, paradermal sections (sections taken parallel to the surface of leaf as 
well as clearing of leaf with 5% sodium hydroxide or epidermal peeling by partial maceration 
employing Jeffrey’s maceration fluid (Sass, 1940) were prepared. Glycerin mounted temporary 
preparations were made for macerated/cleared materials. Powdered materials of different parts 
were cleared with sodium hydroxide and mounted in glycerin medium after staining. Different 
cell components were studied and measured. 
 
PHOTOMICROGRAPHS 
Microscopic descriptions of tissues are supplemented with micrographs wherever 
necessary. Photographs of different magnifications were taken with Nikon labphot 2 
Microscopic unit. For normal observations bright field was used. For the study of crystals, starch 
grains and lignified cells, polarized light were employed. Since these structures have birefringent 
property, under polarized light they appear bright against dark background. Magnifigations of 
the figures are indicated by the scalebars. (Johansen DA, 1940). 
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PREPARATION OF LEAF POWDER  
The leaves were collected and shade dried. It was powdered in a mixer. The coarse  
powder was sieved and was stored  in a well closed container. 
 
POWDER MICROSCOPY 
The coarse powder was  treated with  routine reagents to identify the diagnostic features 
of the plant.. 
QUANTITATIVE  MICROSCOPY OF Commelina benghalensis L.    
         Fresh leaves of Commelina benghalensis L. was subjected to microscopical study includes 
in stomatal number, stomatal index were determined on fresh leaves using standard procedure. 
(Wallis TE. 1953, Wallis TE, 1965).  
 
STOMATAL INDEX 
It is the percentage, which the numbers of stomata from the total number of epidermal 
cells, each stoma being counted as one cell. 
    I. Stomatal index  = S/S+E x 100 
   Where, S = Number of stomata per unit area                                         
E = Number of epidermal cells in the same unit area 
 
DETERMINATION OF STOMATAL INDEX 
The procedure adopted in the determinations of stomatal number was observed under high 
power (45 X).The epidermal cells and the stomata were counted. From these values the stomatal 
index was calculated using the above formula. The results obtained are presented in Table: 2 
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PHYSIO-CHEMICAL PARAMETERS 
The powder was subjected to physiochemical parameters such as foreign organic matter, 
loss on drying, ash values and extractive values with different solvents in increasing order of 
polarity, volatile oil, and total solids. The procedure was adapted as per WHO guidelines 1998,  
and James 1995. 
DETERMINATION OF FOREIGN ORGANIC MATTER  
PROCEDURE 
An accurately weighed 100g of air dried coarse drug and spread out in a thin layer. The 
sample drug was inspected with the unaided eye or with the use of 6x lens and the foreign 
organic matter was separated manually as completely as possible and weighed. The percentage 
of foreign organic matter was calculated with reference to the weight of the drug taken.   
DETERMINATION OF MOISTURE CONTENT (LOSS ON DRYING)  
PROCEDURE 
An accurately weighed 10 g of coarsely powdered drug was placed in a tarred 
evaporating dish. Then the dish was dried at 105oC for 5 h and weighed. The drying and 
weighing was continued at one hour intervals until the difference between the two successive 
weighing is not more than 0.25 %. The loss on drying was calculated with reference to the 
amount of powder taken. 
DETERMINATION OF SWELLING INDEX  
     The swelling index is the volume in ml taken up by the swelling of 1g of plant material under 
specified conditions.  
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PROCEDURE  
           About 1g of the  crude powder was weighed and transferred  to the 25ml of glass 
stoppered measuring cylinder of 25ml of water and was shaken thoroughly for every10 min for 1 
hour. It was allowed to stand at room temperature for 3 hours. The volume in ml occupied by the 
plant material including and sticky mucilage. The weight was calculated with refer to the dried 
weight.  
DETERMINATION OF EXTRACTIVE VALUES 
PROCEDURE 
An accurately weighed 5 g of the air dried coarsely powdered drug was macerated with 
100mL of various solvents of increasing order of polarity (petroleum ether, benzene, chloroform, 
ethyl acetate, ethanol, methanol and water) in a closed flask for 24 h, shaking frequently during 
the first 6 h and allowed to stand for 18 h.  
Thereafter filtered rapidly, taking precautions against loss of ethanol. Then evaporate 25 
mL of the filtrate to dryness in a tarred flat bottomed shallow dish dry at 105o C and weighed. 
DETERMINATION OF ASH VALUES  
ASH CONTENT 
The residue remaining after incineration is the ash content of crude drug, which simply 
represents inorganic salts naturally occurring in the drug or adhering to it or deliberately added 
to it as a form of adulteration. 
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DETERMINATION OF TOTAL ASH  
PROCEDURE 
An accurately weighed 3 g of air dried coarsely powdered drug was taken in a tarred 
silica crucible and incinerated at a temperature not exceeding 450o C, until free from carbon then 
allowed to cool and weighed. The percentage of ash was calculated with reference to the air 
dried drug. 
DETERMINATION OF ACID INSOLUBLE ASH  
PROCEDURE 
The total ash obtained from the previous procedure was mixed with 25 ml of 2 M 
hydrochloric acid and boiled for 5 min in a water bath, and then the insoluble matter was 
collected in an ash less filter paper and washed with hot water, dried and ignited for 15 min at a 
temperature not exceeding 450o C, cooled in desiccators and weighed. The percentage of acid 
insoluble ash was calculated with reference to the air dried drug.  
DETERMINATION OF WATER SOLUBLE ASH  
PROCEDURE 
The total ash obtained from the previous procedure was mixed with 25 ml of water and 
boiled for 5 min in a water bath, and then the insoluble matter was collected in an ash less filter 
paper and washed with hot water, dried and ignited for 15 min at a temperature not exceeding 
450o C, cooled in desiccators and weighed. The insoluble matter was subtracted from the weight 
of the total ash; the difference in weight represents the water soluble ash. The percentage of 
water soluble ash was calculated with reference to the air dried drug. 
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DETERMINATION OF TOTAL SOLIDS  
PROCEDURE           
Preparation of evaporating dishes–If volatile solids are to be measured, ignite clean 
evaporating dishes and watch glasses at 550ºC for 1 hour in a muffle furnace, heat dishes and 
watch glasses at 103ºC to 105ºC for 1 hour in an oven. Cool and store the dried equipment in a 
dessicator. Weigh each dish and watch glass prior to use (record combined weight as “Wdish”). 
 Total solids = WTotal– WDish / WSample – WDish × 100 
The results of physio-chemical parameters were tabulated in Table: 3 
Behavioural characters of the Commelina benghalensis L. (Leaf- crude 
powder) 
Crude powder of Commelina benghalensis L. treated with various chemical reagents (Water, 
Con. HCL, Con.H2SO4, Con HNO3, CH3COOH, Con. HCL+ Water, Con.H2SO4+ Water, Con 
HNO3+ Water, CH3COOH + Water, Aqueous NaOH, Aqueous Fecl3) and their behavioural 
characters are tabulated in Table: 4 
PREPARATION OF HYDROALCOHOLIC EXTRACT OF Commelina 
benghalensis L. 
PROCEDURE 
The shade dried and coarsely powdered leaf of Commelina benghalensis L. (Leaf) was 
defatted with petroleum ether (60-80˚c). The residue was dried and extracted with hydroalcohol 
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(70%) by Maceration until the complete extract of the material and filtered. The extract was 
concentrated under reduced pressure to obtain a solid residue (dark brown). 
The above extract was subjected to physical analysis such as colour, consistency, wt/ 
ml, refractive index and brix. The results obtained are presented in Table: 5 
PART B 
QUALITATIVE AND QUANTITATIVE ANALYSIS 
The hydroalcoholic extract was subjected to qualitative and quantitative analysis. 
Qualitative analysis includes phytochemical screening of secondary metabolites such as 
flavonoids, carbohydrates, alkaloids, glycosides, sterols, tannin, protein, aminoacids, 
carotenoids, volatile oil, quinone, terpenoids, phenolic content and Thin layer chromatography of 
the extract were determined. Quantitative analysis includes estimation of total tannin, total gallic 
acid, total flavonoid contents in terms of total tannic acid equivalent, total gallic acid equivalent, 
total flavonoids equivalent (rutin) and total carotenoid and total chlorophyll content and extract 
were determined.   
QUALITATIVE ANALYSIS 
PRELIMINARY PHYTOCHEMICAL SCREENING 
Hydroalcoholic extract of Commelina benghalensis L. (Leaf) was subjected to 
qualitative chemical analysis. The various chemical tests were performed on this extract and 
aqueous extract for the identification of flavonoids, phenolic compounds, alkaloids, glycosides, 
carbohydrates, carotenoids, proteins, tannin, aminoacids, sterols as per Harborne 1998. 
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TEST FOR ALKALOIDS 
About 2 gm of the powdered material was mixed with 1gm of calcium hydroxide and 5 
mL of water into a smooth paste and set aside for 5 minutes. It was then evaporated to dryness in 
a porcelain dish on a water bath. To this 200 mL of chloroform was added, mixed well and 
refluxed for half an hour on a water bath. Then it was filtered and the chloroform was 
evaporated. To this 5 mL of dilute hydrochloric acid was added followed by 2 mL of each of the 
following reagents.  
MAYER’S TEST: 
A small quantity of the extract was treated with Mayer’s reagent. Cream colour 
precipitate indicates the presence of alkaloids.  
DRAGENDORFF’S TEST: 
A small quantity of the extract was treated with Dragendorff’s reagent. Orange brown 
precipitate indicates the presence of alkaloids. 
WAGNER’S TEST: 
            A small quantity of extract was treated with Wagner’s reagent. Reddish brown precipitate 
indicates the presence of alkaloids. 
HAGER’S TEST: 
A small quantity of extract was treated with Hager’s reagent. Yellow precipitate indicates 
the presence of alkaloids.  
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TEST FOR PURINE GROUP (MUREXIDE TEST) 
The residue obtained after the evaporation of chloroform was treated with 1mL of 
hydrochloric acid in a porcelain dish and 0.1 gm of Potassium chlorate was added and 
evaporated to dryness on water bath. Then the residue was exposed to the vapour of dilute 
ammonia solution. No purple Colour was obtained indicating the absence of purine group of 
alkaloids.  
TEST FOR INDOLE  
To the test solution, add acetic acid and trace amount of anhydrous FeCl3, under  
– lay /H2SO4 intense blue at interface. 
  TEST FOR QUINOLINE (Thalleioquin Test)  
To the extract, add 1 drop of dilute sulphuric acid and 1ml of water. Add bromine water drop 
wise till the solution acquires permanent yellow colour and add 1mL of dilute ammonia solution, 
emerald green colour is produced. The powdered drug when heated with glacial acetic acid in 
dry test tube, evolves red fumes, which condense in the top portion of the tube. The bark, when 
moistened with sulphuric acid and observed under ultraviolet light shows a blue fluorescence 
due to the methoxy group of quinine and quinidine. 
TEST FOR CARBOHYDRATES 
MOLISCH’S TEST 
The extract of the powdered drug was treated with 2-3 drops of 1% alcoholic α naphthol 
and 2mL of concentrated sulphuric acid was added along the sides of the test tube. A purple 
colour indicating the presence of carbohydrates. 
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FEHLING’S TEST 
The extract of the powdered leaf was treated with Fehling’s solution I and II and heated 
on a boiling water bath for half an hour. Red precipitate was obtained indicating the presence of 
free reducing sugars. 
BENEDICT’S TEST 
The extract of the powdered leaf was treated with equal volume of Benedict’s reagent. A 
red precipitate was formed indicating the presence of reducing sugar.  
TEST FOR ANTHRAQUINONE GLYCOSIDES  
BORNTRAGER’S TEST   
The powdered drug was boiled with dilute sulphuric acid, filtered and to the filtrate 
benzene was added and shaken well. The organic layer was separated to which ammonia 
solution was added slowly. No pink colour was observed in ammoniacal layer showing the 
presence of anthraquinone glycosides.  
MODIFIED BORNTRAGER’S TEST 
About 0.1 g of the powdered drug was boiled for 2 minutes with dil.HCl and few drops 
of FeCl3 solution, filtered while hot and cooled. The filtrate was then extracted with benzene and 
the benzene layer was separated. Equal volume of dil.NH3 solution was added to the benzene 
extract. No pink colour was observed in ammoniacal layer showing the presence of glycosides.  
 
 
 
                                                                           MATERIALS AND METHODS 
 
DEPT. OF PHARMACOGNOSY, COP, MMC, MADURAI-20 Page 42 
 
TEST FOR CARDIAC GLYCOSIDES (FOR DEOXYSUGAR)   
KELLER KILIANI TEST   
About 1 g of the powdered leaf was boiled with 10 mL of 70 % alcohol for 2 minutes, 
cooled and filtered. To the filtrate 10 mL of water and 5 drops of solution of lead subacetate 
were added and filtered, evaporated to dryness. The residue was dissolved in 3 mL of glacial 
acetic acid. To these 2 drops of ferric chloride solution was added. Then 3 mL of concentrated 
H2SO4 was added to the sides of the test tube carefully and observed. No reddish brown layer 
was observed indicating the absence of deoxysugars.  
RAYMOND TEST  
Test solution treated with dinitrobenzene in hot methanolic alkali gives violet colour.  
LEGAL’S TEST  
Test solution when treated with pyridine made alkaline by sodium nitro prusside solution 
gives pink to red colour.  
TEST FOR CYANOGENETIC GLYCOSIDES 
Small quantity of the powder was placed in a stoppered conical flask with just sufficient 
water, to cover it. A sodium picrate paper strip was inserted through the stopper so that it was 
suspended in the flask and it was set aside for 2 hours in a warm place. Brick red colour was 
produced on the paper indicating the presence of cyanogenetic glycosides. 
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TEST FOR COUMARIN GLYCOSIDES  
  WITH AMMONIA 
             Take a drop of ammonia on a filter paper; to this add a drop of aqueous extract of    
leaves. Development of fluorescence shows positive test for coumarins.  
WITH HYDROXYLAMINE HYDROCHLORIDE  
To ethereal extract, added one drop of alcoholic KOH. It was then heated, cooled and acidified 
with 0.5N hydrochloric acid. Violet colour developed upon addition of a drop of 1 % w/v FeCl3 
indicated presence of coumarins.  
TEST FOR STEROLS 
The powdered drug was first extracted with petroleum ether and evaporated to a residue. 
Then the residue was dissolved in chloroform and tested for sterols.  
SALKOWSKI’S TEST   
 A few drops of concentrated sulphuric acid was added to the above solution, shaken well 
and set aside. The lower chloroform layer of the solution turned red in colour indicating the 
presence of sterols. 
TEST FOR LIBBERMANN – BURCHARD’S   
To the chloroform solution a few drops of acetic anhydride and 1 mL of concentrated 
sulphuric acid were added through the sides of the test tube and set aside for a while. At the 
junction of two layers a brown ring was formed. The upper layer turned green indicating the 
presence of sterols.  
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TEST FOR SAPONINS  
FROTH TEST  
0.1g of powder was vigorously shaken with 5ml of distilled water in a test tube for 30 seconds 
and was left undisturbed for 20 min, persistent froth indicated presence of saponins. 
 
TEST FOR TANNINS  
 FERRIC CHLORIDE  
 Small quantity of the powdered drug was extracted with water. To the aqueous extract 
few drops of ferric chloride solution was added. Bluish black colour was produced indicating the 
presence of tannins.  
GOLD BEATER’S SKIN TEST 
Add 2 % hydrochloric acid to all small piece of g old beater’s skin, rinses it with distilled 
water and place in the solution to be tested for five minutes. Then give wash of distilled water 
and transfer to a 1% ferrous sulphate solution. A brown or black colour on the skin indicates 
presence of tannin.    
TEST FOR PHENOLIC COMPOUNDS  
FERRIC CHLORIDE  
A small quantity of the powdered drug was extracted with water. To the alcoholic extract 
few drops of ferric chloride solution was added. Bluish black colour was produced indicating the 
presence of tannins.  
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TEST FOR FOLIN COICALTEU REAGENT 
    To a drop of methanolic extract of a few drop of Folin Ciocalteu reagent was added, 
development of bluish green colour showed presence of phenol.   
TEST FOR FLAVONOIDS 
SHINODA’S TEST 
 Little of the powdered drug was heated with alcohol and filtered. To the test solution magnesium 
turnings and few drops of concentrated hydrochloric acid were added. Boiled for five minutes. 
Red colour was obtained indicating the presence of flavonoids.  
ALKALI TEST 
          To the small quantity of test solution 10% aqueous sodium hydroxide solution was added. 
Yellow orange colour was produced indicating the presence of flavonoids.  
LEAD ACETATE 
           To the test solution add a mixture of 10 % lead acetate in few drops added. It gives white 
precipitate.  
TEST FOR ACID 
To the small quantity of test solution, few drops of concentrated sulphuric acid were added. 
Yellow orange colour was obtained indicates the presence of flavonoids.  
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TEST FOR PROTEIN AND AMINO ACIDS  
 MILLON’S TEST  
 Small quantity of acidulous – alcoholic extract of the powdered drug was heated with 
Millon’s reagent. White precipitate turned red on heating indicate the presence of proteins. 
BIURET TEST 
To one portion of acidulous – alcoholic extract of the powdered drug one ml of 10% 
sodium hydroxide solution and one drop of dilute copper sulphate solution were added. Violet 
colour was obtained indicating the presence of proteins.  
NINHYDRIN TEST   
To the test solution add Ninhydrin solution, boil, violet colour indicates presence of 
amino acid.  
TEST FOR SULPHUR CONTAINING AMINO ACID  
5 ml test solution is mixed with 2 ml 40 % sodium hydroxide and 2 drops of 10% lead 
acetate solution. Then boil the solution turned black or brownish due to PLS formation.  
TEST FOR TERPENOIDS 
 Little of the powdered drug was extracted with chloroform and filtered. The filtrate was 
warmed gently with tin and thionyl chloride. Pink colour solution appeared which indicated the 
presence of terpenoids.   
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TEST FOR CAROTENOIDS ( Carr-Price reaction) 
Extract treated with concentrated sulphuric acid and with a chloroform solution of 
antimony trichloride. Deep blue colour appeared which indicated the presence of carotenoids.  
TEST FOR VOLATILE OIL 
Weighted quantity (250 gm) of fresh leaves were extracted and subjected to hydro 
distillation using volatile oil estimation apparatus.   
TEST FOR FIXED OIL   
 A small amount of the powder was pressed in between in the filter paper and the paper 
was heated in an oven at 1050 C for 10 minutes. A translucent greasy spot appeared indicating 
the papers.            
TEST FOR GUM 
         The small quantity of extract was added with few drops of alcohol to form white 
precipitate which indicates the presence of gum. 
TEST FOR  MUCILAGE 
         Few ml of aqueous extract was prepared from the powdered crude drug was treated 
with ruthentium red. Red colour was produced indicating the presence of mucilage. 
TEST FOR BETACYANINS 
To 1 ml of plant extract, 1 mL of 2N NaOH was added and heated for 5 minutes at 1000C. 
Formation of yellow colour indicated the presence of betacyanins.  
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TEST FOR ANTHOCYANIN 
About 0.2g of plant extract was weighed in separate test tube, 1ml of 2N sodium hydroxide was 
added, and heated for 5 minutes. Observed for the formation of bluish green colour which 
indicates the presence of anthocyanin. 
TEST FOR LEUCOANTHOCYANINS 
To 1 ml of plant extract , 1 ml of isoamyl alcohol was added. Formation of red colour indicated 
the presence of leucoanthocyanins. 
TEST FOR QUINONES 
To 1 ml of plant extract, 1 mL of conc. H2SO4 was added. formation of red colour indicated the 
presence of quinones. 
TEST FOR EMODINS 
The dry extract was added to 25% ammonia solution. The formation of a cherry red colour 
solution indicated the presence of emodins.   
TEST FOR COUMARINS  
To 1 ml of plant extract, 3 ml of NH4OH and 2mL of benzene was added. Formation of red 
colour indicated the presence of  coumarin.  
TEST FOR RESINS 
 The extracts were treated with acetone. A small amount of water was then added and 
shaken. Appearence of turbidity indicates the presence of resins.  
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TEST FOR PHLOBATANNINS 
About 2 ml of aqueous extract was added to 2ml of 1% HCl and the mixture was boiled. 
Deposition of a red precipitate was an evidence for the presence of phlobatannins. 
The results are presented in the Table: 6 
THIN LAYER CHROMATOGRAPHY (TLC) 
 The hydroalcoholic extract was subjected to TLC by using different mobile phases as per 
Harborne J.B 1998, wagner 1996, to identify the Rf values. It was carried out using TLC plates. 
It was tested for its phenolic and flavonoid content by using mobile phases such as Acetic acid : 
Chloroform (1:9), Ethyl acetate : Benzene (9:11), Chloroform : Ethyl Acetate (60:40), Ethyl 
Acetate : Formic Acid : Glacial Acetic Acid : Water (100:11:11:26). Rf value was measured 
in UV light at different nanometers. 
The results are depicted in Table: 7 
QUANTITATIVE ESTIMATION OF PHYTO CONSTITUENTS 
 DETERMINATION OF GALLIC ACID EQUIVALENT IN (HAECB) (Singleton et al., 
1999) 
Principle 
Total phenolic content of the various concentrations of HAECB was determined by 
Folin-ciocalteu reagent method. The hydroxyl group (OH) of phenolic compounds reduce the 
phosphomolybdic acid to molybdenum blue in the presence of alkaline medium (present in Folin 
reagent). The blue coloured complex was then spectrophotometrically measured at 760nm.  
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Instrument 
UV Visible spectrophotometer, Shimadzu (Model 1800). 
Reagents required 
• Folin-Ciocalteu Reagent (1N)  
• Sodium carbonate solution (10%)  
• Standard Gallic acid solution  
 
Procedure 
About 1 mL (1mg/ml and 0.5 mg/mL) of hydroalcoholic extract of Commelina 
benghalensis L. (Leaf) (HAECB), 0.5 mL of Folin-ciocalteu reagent (1N) were added and 
allowed to stand for 15 minutes. Then 1 mL of 10% sodium carbonate solution was added to the 
above solution. Finally the mixtures were made up to 10 mL with distilled water and allowed to 
stand for 30 minutes at room temperature and total phenolic content was determined 
spectrophotometrically at 760nm wavelength.  
The calibration curve was generated by preparing gallic acid at different concentration (5, 
10, 15, 20 and 25 µg/mL). The reaction mixture without sample was used as blank. Total 
phenolic content of HAECB extract is expressed in terms of mg of Gallic acid equivalent per gm 
of extract (mg GAE/g). The results are tabulated in Table: 8 and the calibration graph was 
presented in Fig: 14 
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DETERMINATION OF TANNIC ACID  EQUIVALENT IN (HAECB) 
 (RabiaNaz and AsghariBano, 2013) 
Principle 
Total tannin content of extract was determined by Folin Denis reagent method. Tannin 
like compounds reduces phosphotungstomolybdic acid in alkaline solution to produce a highly 
coloured blue solution. The intensity of which is proportional to the amount of tannins and it was 
estimated by spectrophotometer at 700 nm.  
Instrument 
UV Visible spectrophotometer, Shimadzu (Model 1800). 
Reagents required 
• Folin Denis Reagent   
• Sodium carbonate solution (10%)   
• Standard tannic acid solution.   
Procedure 
0.2 mL of (1 mg/mL) hydroalcoholic extract of  Commelina benghalensis L. (Leaf) was made up 
to 1 mL with distilled water. Then add 0.5 mL of Folin Denis reagent and allowed to stand for 15 
min, then 1 mL of sodium carbonate solution was added to the mixture and it was made up to 10 
mL with distilled water. The mixture was allowed to stand for 30 min at room temperature and 
the tannin content was determined spectrophotometrically at 700nm.The calibration curve was 
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generated by preparing tannic acid at different concentration (5, 10, 15, 20 and 25µg/mL). The 
reaction mixture without sample was used as blank. The total tannin content in the leaf extract 
was expressed as milligrams of tannic acid equivalent per gm of extract. The results are tabulated 
in Table: 9 and the calibration graph was presented in Fig: 15 
DETERMINATION OF RUTIN (FLAVONOID) EQUIVALENT IN (HAECB) 
 (Zhishen et al., 1999)  
Principle 
Flavonoids present in the extract form, a charge transfer complex with several heavy 
metals to give a characteristic colour. In this reaction, the high electron positive nature of 
aluminium attracts the atomic nuclei of the aromatic rings in the flavonoids. Then it will react 
with potassium acetate in alkaline medium to form a pink coloured complex that is measured 
spectrophotometrically at 415 nm.  
Instrument 
UV Visible spectrophotometer, Shimadzu (Model 1800). 
Reagents required 
• 10% aluminium chloride  
• 1M potassium acetate  
• Standard rutin 
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Procedure 
1mL of hydroalcoholic extract of Commelina benghalensis L. (Leaf), 0.1 mL of 
aluminium chloride solution, 0.1 mL of potassium acetate solution and 2.8 mL of ethanol were 
added and the final volume was then made up to 5 mL with distilled water. After 20 min the 
absorbance was measured at 415 nm.  
A calibration curve was constructed by plotting absorbance reading of rutin at different 
concentrations (5, 10, 15, 20 and 25 µg/mL). The sample without aluminium chloride was used 
as a blank. The total flavonoid content in the extract was expressed as milligrams of rutin 
equivalent per gram of extract. The results are tabulated in Table: 10 and the calibration graph is 
presented in Fig: 16 
 
DETERMINATION OF CHLOROPHYLL “a”, CHLOROPHYLL “b”, TOTAL 
CHLOROPHYLL AND TOTAL CAROTENOID (Dhruve JJ et al., 2015) 
Total chlorophyll, Chlorophyll “a”, chlorophyll “b” and total carotenoids were estimated 
as described by Hiscox and Israelstam (1979). 50 mg fresh leaves were cut into small pieces and 
kept in 10ml dimethyl sulfoxide (DMSO) containing tube overnight. The extract was filtered 
through Whatman No.1 filter paper. Absorbance was measured in spectrophotometer at 645 nm 
and 663 nm for determination of total chlorophyll and absorbance was measured in 
spectrophotometer at 453nm for determination of total carotenoids. 
                                                               12.7 × O.D at 663 nm – 2.69 × O.D at 645 ×10 
Chlorophyll “a” (mg/g fresh tissue) =                               1000 × 0.05 
 
                                                                           MATERIALS AND METHODS 
 
DEPT. OF PHARMACOGNOSY, COP, MMC, MADURAI-20 Page 54 
 
                                                22.9 × O.D at 645 nm – 4.68 × O.D at 663 × 10 
Chlorophyll “b” (mg/g fresh tissue) =                                  1000 × 0.05 
 
 
     20.2 × O.D at 645 nm + 8.02 × O.D at 663 × 10 
Total chlorophyll (mg/g fresh tissue) =                              1000 × 0.05 
  
Total carotenoid  =  0.216 × O.D 663 – 1.22 × O.D 645 – 0.354 × O.D at 663 + O.452 × O.D 453 
(mg/g fresh tissue) 
The results are depicted in Table: 11 & 12 
LUTEIN 
Carotenoids are fat soluble nutrients and categorized as either xanthophylls or carotenes 
according to their chemical structure. They are very important natural antioxidants that have 
wide application on human health benefits. The pigment properties of carotenoids have granted 
to some extensive application in the food and feed industries (Alves-Rodrigues & Shao, 2004). 
Carotenoids are naturally found in edible leaves, flowers and fruits. Currently attention is being 
drawn towards exploring plant sources for substances that provide nutritional and pharmaceutical 
advantages to humans. Green leafy vegetables (GLVs) are good sources of minerals and 
vitamins and also have health benefits. GLVs are rich sources of carotenoids especially lutein. 
Lutein a member of the xanthophylls family of carotenoids, decreases the risk for eye diseases 
such as Age-related Macular Degeneration (Seddon et al., 1994), protects the skin (Alves-
Rodrigues & Shao, 2004), reduces cardiovascular problems, aging etc., and is being 
recommended for human, veterinary and poultry uses. 
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Lutein and zeaxanthin belong to the xanthophyll family of carotenoids and are the two 
major components of the macular pigment of the retina. Lutein and zeaxanthin differ from other 
carotenoids in that they each have two hydroxyl groups, one on each side of the molecule. 
Zeaxanthin is a stereoisomer of lutein, differing only in the location of a double bond in one of 
the hydroxyl groups. The hydroxyl groups appear to control the biological function of these two 
xanthophylls. The macula lutea or “yellow spot” in the retina is responsible for central vision and 
visual acuity. Lutein and zeaxanthin are the only carotenoids found in both the macula and lens 
of the human eye, and have dual functions in both tissues – to act as powerful antioxidants and to 
filter high-energy blue light. Lutein is found in high amounts in human serum. In the diet it is 
found in highest concentrations in dark green, leafy vegetables (spinach, kale, collard greens, and 
others), corn, and egg yolks. Zeaxanthin is the major carotenoid found in corn, orange peppers, 
oranges, and tangerines. In addition to playing pivotal roles in ocular health, lutein and 
zeaxanthin are important nutrients for the prevention of cardiovascular disease, stroke, and lung 
cancer. They may also be protective in skin conditions attributed to excessive ultraviolet (UV) 
light exposure. 
 
Lutein and zeaxanthin are powerful antioxidants, and lutein is widely known as the 
primary nutrient for protecting ocular function. It has long been thought that carotenoid intake 
also reduces the risk of certain forms of cardiovascular disease, stroke, and cancer. Lutein and 
zeaxanthin may prevent cellular damage in these conditions by quenching singlet oxygen or 
neutralizing photosensitizers. Lutein and zeaxanthin inhibit lipid peroxidation, a likely factor in 
the etiology of both retinal and cardiovascular disease. The presence of adhesion molecules on 
endothelial cell surfaces is a marker of atherosclerosis pathogenesis. In vitro research has 
demonstrated lutein incubation with cultured endothelial cells effectively inhibits the expression 
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of these adhesion molecules. other research has found lutein and zeaxanthin can inhibit 
thickening of the walls of carotid arteries and LDL-induced migration of monocytes to human 
artery cell walls. These are potential mechanisms for luteinʼs protective effect in cardiovascular 
disease. In the case of skin health, lutein, zeaxanthin, and other carotenoids appear to be depleted 
in the skin under conditions of prolonged UV light exposure. Skin exposure to UV rays 
generates reactive oxygen species, inflammation in skin cells, and erythema. Intake of dietary 
antioxidants, including lutein and zeaxanthin, reduces this inflammatory response, as carotenoids 
are poor absorbers of UV light. 
 
ISOLATION OF LUTEIN (Vatsala TM and Rekha R, 2013) 
50 G of crude powder extracted with Diethyl ether : Methanol (2:1). 
 
DE/Met (300 ml) solvents added and incubated for 30 minutes with agitation. 
 
 Filtered and extraction was repeated upto 600 ml solvents. 
 
The crude extract after removal of solvents were re-constituted with known volume of 
DE/Met (2:1v/v). 
 
An aliquot of crude extract was analyzed on UV-Vis spectrophotometer from 300-700 nm to 
check the presence of chlorophyll and lutein. 
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Crude extracts partitioned with saturated Nacl 1:1 (v/v) at (26 ± 2ºc) for 5 min followed by 
overnight saponification with methanolic KOH 10% at (26 ± 2ºc) .  
 
Saponified mixtures were transferred to separating funnel and equal volume of DE was added 
for further carotenoid separation from chlorophyll and incubated at (26 ± 2ºc) for 5 min, 
followed by addition of equal volume of distilled water to the saponified mixture. 
 
Shaken vigorously and allowed to stand for 15 – 20 min at 26 ± 2ºc. 
 
 
 
 
  
 Top layer washed repeatedly with distilled water for complete removal of alkali. 
 
Top layer was analysed by spectrophotometer from 300 – 700 nm. 
 
 
 
 
 
Bottom layer was removed 
                                                                           MATERIALS AND METHODS 
 
DEPT. OF PHARMACOGNOSY, COP, MMC, MADURAI-20 Page 58 
 
UV SPECTRAL STUDIES (Vatsala TM and Rekha R, 2013) 
Lutein and Chlorophyll 
 Aliquot of crude extract was transferred to cuvette (quartz) and was scanned under UV range 
from 300 – 700 nm in the UV – Visible spectrophotometer to check the presence of chlorophyll 
and lutein. The results are tabulated in Table: 13 and the spectrum was presented in Figure: 17 
Lutein 
 The isolated compound lutein was dissolved in diethyl ether and transferred to cuvette 
(quartz) and was scanned under UV range from 300 – 700 nm in the UV – Visible 
spectrophotometer. The results are tabulated in Table: 14 and the spectrum was presented in 
Figure: 18 
NMR SPECTRAL STUDIES (Omayma A. Eldahshan et al., 2013) 
1H NMR 
The Isolated compound was dissolved in Duterated chloroform (CDCL3) and the NMR spectrum 
was obtained by using UXNMR Bruker Analytische Messtechnik Gmbh. Chemical shift values 
are tabulated in Table: 15 & 16 and the spectrum was presented in Figure: 19. 
13C NMR 
The Isolated compound was dissolved in Duterated chloroform (CDCL3) and the NMR spectrum 
was obtained by using UXNMR Bruker Analytische Messtechnik Gmbh. Chemical shift values 
are tabulated in Table: 17 and the spectrum was presented in Figure: 20. 
GC-MS STUDIES  
 The isolated compound was subjected to GC-MS studies and the results are depicted in              
Table: 18 and the spectrum was presented in Figure: 21-21.24. 
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PART C 
PHARMACOLOGICAL STUDIES 
SUN PROTECTION FACTOR (Manoj A. Suva; 2014) 
Solar ultraviolet radiation (UVR) is divided into three categories UV-C (200-280 nm), 
UV-B (280-320) and UV-A (320- 400 nm). UV light has been classified by WHO as 
carcinogenic and produces several adverse effects including mutagenicity, immune depression of 
the skin, accelerated skin ageing and photo dermatoses (Nohynek and Schaefer, 2001). The most 
biologically damaging radiation UV-C has been filtered out by the ozone layer and it is mainly 
UV-B that is responsible for causing the adverse effects of the UV radiation (Kaur and Saraf, 
2010; Mishra et al., 2011). Application of sunscreen to the skin changes the way the body reacts 
to the sun rays (Mishra et al., 2012). Sunscreens and sun blocks are chemicals that absorb or 
block UV rays and show a variety of immunosuppressive effects of sunlight. There are several 
agents available from both synthetic and natural sources with UV-filtering properties. Given 
their potential to produce considerable human local and systemic exposure, UV filters have to be 
safe (Nohynek et al., 2010). Synthetic UV filters are known to have potential toxicity in humans 
and also showed ability to interfere only in selected pathways of multistage process of 
carcinogenesis (Chanchal and Saraf, 2009). In contrast, herbal botanical sunscreens are safe, 
widely accepted by consumers and also work in various ways, playing multiple roles in 
ameliorating the process of carcinogenesis (Guyer et al., 2003). 
 
SPF is a number given to sunscreen formulations to determine its effectiveness and it is 
also useful when applied about 2mg/cm . SPF numbers indicates the time period for the product 
up to which it protects the person while stay in the sun before burning. In order to protect the 
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skin against ultraviolet radiation, the formulation should have good SPF number and also the 
formulation should have wide range of absorbance between 290 and 400nm range. In the present 
research work, isolated lutein from Commelina benghalensis L. were subjected for SPF 
evaluation by ultraviolet spectroscopic method. SPF value for sunscreen above 2 is considered as 
having good sunscreen activity. 
 
The effectiveness of a sunscreen is usually expressed by sun protection factor (SPF) 
which is the ratio of UV energy required to produce a minimal erythemal dose (MED) in 
protected skin to unprotected skin. A simple, rapid and reliable in vitro method of calculating the 
SPF is to screen the absorbance of the product between 290-320 nm at every 5 nm intervals. SPF 
can be calculated by applying the following formula known as Mansur equation (Kaur and Saraf, 
2010; Mishra et al., 2012): 
 
                  SPF = CF × ∑  𝐄𝐄 ሺ𝛌ሻ  ×  𝐈 ሺ𝛌ሻ ×  𝐀𝐛𝐬 ሺ𝛌ሻ  ଷଶ0ଶ90    
Where CF = correction factor (10), EE (Ȝ) = erythmogenic effect of radiation with wavelength Ȝ, 
Abs (Ȝ) = Spectrophotometric absorbance values at wavelength Ȝ. The values of EE x Ȝ are 
constants 
MATERIALS AND METHODS 
MATERIALS 
 Ethanol, Isolated Lutein from Commelina benghalensis L. ,  
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SAMPLE PREPARATION 
Lutein isolated from Commelina benghalensis L. 50 mg of isolated lutein is dissolved in 50ml of 
ethanol (1000 µg/ml). From this stock solution three different concentration (50, 100, 200 µg/ml) 
was prepared  
METHODS 
 50, 100, 200 µg/ml of isolated lutein were subjected for SPF evaluation by 
ultraviolet spectroscopic method.  Then spectrophotometer readings (Shimadzu 1800 UV-VIS 
Spectrophotometer) of these solutions were taken in wavelength ranging from 290 to 320 at 5nm 
interval and readings were noted down. SPF for isolated lutein can be calculated by applying the 
following formula known as Mansur equation (Kaur and Saraf, 2010; Mishra et al., 2012): 
      
                      SPF = CF × ∑  𝐄𝐄 ሺ𝛌ሻ ×  𝐈 ሺ𝛌ሻ ×  𝐀𝐛𝐬 ሺ𝛌ሻ  ଷଶ0ଶ90    
Where CF = correction factor (10), EE (Ȝ) = erythmogenic effect of radiation with 
wavelength Ȝ, Abs (Ȝ) = Spectrophotometric absorbance values at wavelength Ȝ. The values of 
EE x Ȝ are constants. 
The results of sun protection factor of lutein is depicted in Table: 20, 21 & 22.  
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ANTI-INFLAMMATORY ACTIVITY 
Medicinal and culinary herbs are rich sources of anti-inflammatory compounds such as 
flavonoids. Pharmaceutical drugs are built upon a single molecule while herbal remedies contain 
different active ingredients. One of the wide spread complaint against modern medicines is its 
side effect that can be attributed to a single biochemical pathway that is triggered by the 
molecule of interest. On the contrary herbal medicines mediate multifaceted biochemical attack 
on inflammation due to the diversity and synergy of the anti-inflammatory compounds. 
Inflammation is a protective response by our immune system against organisms which cause cell 
injury (e.g., microbes, toxins) and deals with the consequences of such injury. It may be acute or 
chronic, depending up on the nature of stimulus and the effectiveness of initial reaction in 
eliminating the stimulus or the damaged tissues. The main components of inflammation are a 
vascular reaction and a cellular response, both are activated by mediators that are derived from 
plasma proteins and various cells. The outcome of acute inflammation is either elimination of the 
noxious stimulus followed by decline of the reaction and repair of the damaged tissue, or 
persistent injury resulting in chronic inflammation. 
 
Inflammation is a complex biological response of vascular tissue to harmful stimuli, 
pathogens, irritants characterized by redness, warmth, swelling and pain. Prolonged 
inflammation leads to the rheumatoid arthritis, atherosclerosis, hey fever, ischemic heart diseases 
and inflammation is a common manifestation of infectious diseases like leprosy, tuberculosis, 
syphilis, asthma, inflammatory bowel syndrome, nephritis, vascularitis, celiac diseases, auto-
immune diseases etc. 
Anti-inflammatory drugs like NSAIDs used to reduce the swelling and pain of 
inflammation. But these agents carry the risk of gastro-intestinal toxicity, cardiovascular and 
other toxicity for prolonged use. For these reason, there is a need for ant-inflammatory drugs 
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having less severe side effects to use for chronic inflammatory disease as well. Therefore, in 
recent time, more interest is shown in alternative and natural drugs for treatment of various 
diseases, but there is a lack of proper scientific evidence. 
 
 Leukocytes, the key players of inflammatory response, can eliminate microbes and dead 
cells by phagocytosis, followed by their destruction in phagolysosomes. Destruction is caused by 
free radicals generated in activated leukocytes (neutrophils and monocytes) and lysosomal 
enzymes. Enzymes and reactive oxygen species may be released into the extracellular 
environment where it acts as mediators of inflammation. Such mediators are mainly arachidonic 
acid metabolites, generated through Cyclooxygenase and Lipoxygenase pathways. Most of the 
anti-inflammatory drugs are targeted on these pathways.  
In a different approach, rather than blocking a particular mediator or its pathway, 
preventing the release of inflammatory mediators could be considered as a better option. The 
possibility of this approach is revealed in this research by studying the ability of the plant extract 
to prevent the lysosomal membrane destruction. An effective way to study this activity in vitro is 
to study the HRBC membrane stabilization activity of the plant extract. Lysosomal membrane 
and RBC membrane are similar in structure apart from the fact that luminal surface of the 
lysosomal membrane contains a glycoprotein coat which protects the membrane from digestion 
by lysosomal acid hydrolases. This method has been used in most preliminary anti-inflammatory 
screening procedures. Plants produce different bioactive compounds using secondary metabolic 
pathways in response to specific environmental stimuli such as herbivore-induced damage, 
pathogen attacks, or nutrient depravation. These secondary metabolites can be unique to specific 
species or genera and perform a host of general, protective roles including anti-inflammatory and 
antioxidant activities.  
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Commelina benghalensis L. commonly known as ‘Benghal dayflower’ or ‘tropical 
spiderwort’ is a perennial herb and its young leaves are eaten as vegetables. It is used as a folk 
medicine for the variety of ailments in the Indian subcontinent. It has antibacterial, sedative, 
anxiolytic, analgesic and anticancer properties and used against diuretic, febrifuge, inflammatory 
and leprosy problems. The phytochemical studies of Commelina benghalensis L. revealed the 
presence of flavonoids and phenolic compounds. The current study focuses on the evaluation of 
in vitro anti-inflammatory property and phytochemical nature of the leaf extracts of Commelina 
benghalensis L.   
 
INVITRO ANTI-INFLAMMATORY ACTIVITY SCREENING BY MEMBRANE 
STABILIZATION STUDY (Sadique et al.,1989) (Oyedapo et al., 2012) 
 
Principle 
 The method of Sadique et al., (1989) and modified by Oyedapo and Famurewa (1995) 
and Oyedapo et al., (2012) was employed in the membrane stabilizing activity assay. When 
RBCs are subjected to heat and treatment with hyposaline they release haemoglobin which has a 
maximum absorbance at about 560 nm. The capacity of the extract to reduce hyposaline and heat 
induced lysis is basis of the assay. 
 
Instrument 
 Shimadzu UV visible spectrophotometer, Model 1800 
 
Materials required 
 70% Hydroalcoholic extract of Commelina benghalensis L. 
 0.2 M Sodium phosphate buffer (pH 7.4) 
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 0.36% w/v Hyposaline 
 10% v/v HRBC suspension in isosaline 
 
Preparation of HRBC suspension in isosaline 
 The human erythrocytes suspension was used for the in-vitro membrane stabilization 
assay. Blood was collected from the healthy volunteers who had not consumed any NSAIDs for 
two weeks prior to the experiment. The blood was mixed with equal volume of Alsever’s 
solution (2% dextrose, 8.0% sodium citrate, 0.5% citric acid, 0.42% sodium chloride) and 
centrifuged at 3000 rpm. The packed cells were washed with isosaline and a 10% v/v erythrocyte 
suspension in isosaline was prepared. 
 
Procedure  
 The assay mixture consist of 2 ml of hyposaline and 1 ml of phosphate buffer and 
varying volumes (0.1 to 0.5 ml) of HAECB extract at different concentration (10, 20, 30, 40, 50 
µg/ml) and 0.5 ml HRBC suspension in isosaline, then the final volume were made upto 4.5 ml 
with isosaline. The control was prepared as mentioned above without the test extract, while drug 
control was also prepared similarly but without HRBC suspension. The reaction mixture was 
incubated at 56º C for 30 min in a water bath, then the tube was cooled under running water. 
Then the absorbance of the released haemoglobin was measured at 560 nm. Diclofenac sodium 
was used as a reference standard. The percentage membrane stabilization activity of the 
compounds were determined by the formula  
                                          [ A control – ( Atest – Aproduct control)   
          % Membrane stabilization =                                                                       × 100 
                                                                                         Acontrol 
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Where 
 Acontrol  - Absorbance in control 
 Atest  - Absorbance in test 
 Aproduct control - Absorbance in product control 
 
The results of membrane stabilization study is depicted in Table: 23 and the calibration was 
presented at Figure: 22  
 
 
RHEUMATOID ARTHRITIS 
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint 
swelling, synovial inflammation and cartilage destruction and commonly lead to significant 
disability. According to WHO, 0.3-1% of the world population is affected from rheumatoid 
arthritis (RA) and among them females are three times more prone to the disease as compared to 
males. It caused by number of proinflammatory molecules released by macrophages including 
reactive oxygen species and ecosanoids such as prostaglandins, leukotrines and cytokines. The 
regulation of these mediators secreted by macrophages and other immune cells and modulation 
of arachidonic acid metabolism by inhibiting enzymes like cox and lox are the potential target 
for chronic inflammatory conditions. Eventhough various categories like immunosuppressants, 
NSAIDs, steroidal anti-inflammatory drugs are being used till now, the potential side effects give 
a limitation for their use. Now it is a growing concern all over for the development of new safe, 
potent, less toxic antiarthritic drug . Hence, there is a need to explore for more naturally available 
alternatives, so that their therapeutic values can be assessed and expanded. 
 
                                                                           MATERIALS AND METHODS 
 
DEPT. OF PHARMACOGNOSY, COP, MMC, MADURAI-20 Page 67 
 
Plants are one of the most important sources of medicines. India is known as the 
“Emporium of Medicinal plants” due to availability of several thousands of medicinal plants in 
the different bioclimatic zones anti-inflammatory diseases including rheumatoid arthritis are still 
one of the main health problems of the world’s population. The use of natural remedies for the 
treatment of inflammatory and painful conditions has a long history, starting with Ayurvedic 
treatment, and extending to the European and other systems of traditional medicines. Plant drugs 
are known to play a vital role in management of inflammatory diseases. 
 
INVITRO ANTIARTHRITIC ACTIVITY BY PROTEIN DENATURATION METHOD 
(Lavanya R et al., 2010) 
 Rheumatoid arthritis is an autoimmune disorder. One among the cause for the disease is 
due to the denaturation of the protein. Antiarthritic activity was studied by inhibition of protein 
denaturation method. 
Materials required  
 70%  Hydroalcoholic extract of Commelina benghalensis L. 
  Diclofenac sodium 
 Bovine serum albumin (5% w/v aqueous solution) 
 Phosphate buffer (PH 6.3) 
Instrument 
 Shimadzu UV visible spectrophotometer, Model 1800 
EXPERIMENTAL PROTOCOL 
The following four solutions were prepared 
1. Test solution (0.5 ml) 
The test solution consists of 0.45 ml bovine serum albumin (5% w/v aqueous solution) 
and 0.05 ml of HAECB (10, 20, 30, 40, and 50 µg/ml concentration). 
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2. Test control solution (0.5 ml) 
The test control solution consists of 0.45 ml bovine serum albumin and 0.05 ml distilled 
water. 
3. Product control (0.5 ml) 
The product control consists of 0.45 ml of distilled water and 0.05 ml of HAECB ( 10, 
20, 30, 40, and 50 µg/ml concentration ). 
4. Standard solution 
 Standard solution consists of 0.45 ml of bovine serum albumin and 0.05 ml of Diclofenac 
sodium solution. 
 All the above test samples was adjusted to pH 6.3 using a small amount of 1N 
hydrochloric acid. They were incubated at 37º C for 20 minutes and heated at 57º C for 3 
minutes. Allow to cool and about 2.5 ml of phosphate buffer (pH 6.3) was added to all the above 
solution. The absorbance was measured using UV spectrophotometer at 416 nm. The percentage 
inhibition of protein denaturation was calculated using the formula : 
                                                      OD of test solution – OD of product control 
Percentage inhibition =100 -                                                                                  × 100 
                                                                       OD of test control 
 
The control represents 100% protein denaturation. The results were compared with the 
standard drug diclofenac sodium treated sample.  
 
The results of protein denaturation is depicted in Table: 24 and the calibration was presented at 
Figure: 23  
ANTIOXIDANT ACTIVITY 
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 Oxygen derived free radicals like superoxide, hydrogen peroxide, hydroxyl and nitric 
oxide radicals are collectively termed as reactive oxygen species (ROS) and have been 
implicated in the pathogenesis of various diseases.  (Halliwell, 1997; Lata and Ahuja, 2003). 
When generation of ROS overtakes the antioxidant defense of the cells, the free radicals start 
attacking the cell proteins, lipids and carbohydrates and this leads to a number of physiological 
disorders (Yu, 1992; Campbell and Abdulla, 1995; Cotran et al., 1999). The oxidative stress has 
also been implicated in the pathogenesis of diabetes, liver damage, nephrotoxicity, inflammation, 
cancer, cardiovascular disorders, neurological disorders, as well as in the process of aging. Many 
plants contain substantial amounts of antioxidants and can be utilized to scavenge the excess free 
radicals from human body. 
Commelina benghalensis L. commonly known as ‘Benghal dayflower’ or ‘tropical 
spiderwort’ is a perennial herb and its young leaves are eaten as vegetables. It is used as a folk 
medicine for the variety of ailments in the Indian subcontinent. It has antibacterial, sedative, 
anxiolytic, analgesic and anticancer properties and used against diuretic, febrifuge, inflammatory 
and leprosy problems. Earlier phytochemical studies of Commelina benghalensis L. revealed the 
presence of lutein and its isomer zeaxanthin. The plant is also reported to contain alkaloids, wax, 
vitamin C and higher levels of vitamin A and β-carotene. The antioxidant activity DPPH radical 
scavenging activity of the hydro methanol extract of C. benghalensis has been reported by 
(Hasan et al., 2009)  
Although some ethnobotanical and phytochemical information are available on these 
plants, their nutraceutical values have not yet been exposed. Therefore the antioxidant potential 
of these plants was investigated by employing different in vitro free radical scavenging assays. 
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INVITRO ANTIOXIDANT ACTIVITY  
DETERMINATION OF SCAVENGING ACTIVITY AGAINST HYDROGEN  
PEROXIDE (Rana MG et al., 1996) 
Principle  
The principle is based on the capacity of the extract to decompose the hydrogen peroxide to 
water. H2O2 in the presence of O2
- can generate highly reactive hydroxyl radicals via the metal, 
the scavenging of H2O2 in cells is critical to avoid oxidative damage. Thus, the scavenging of 
hydrogen peroxide is an important antioxidant defence mechanism.  
Fe2+ + H2O2   Fe3+ + OH + OH- 
The decomposition of hydrogen peroxide to water involves the transfer of electrons as in the 
equation.  
                                              H2O2 + 2H+ + 2e-  2H2O  
Reagents 
• 6% hydrogen peroxide diluted with water in the ratio of 1:10  
• 0.1 M Phosphate buffer  (pH 7.4) 
 
 
Procedure 
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To 1 mL of test solutions of different concentrations, 3.8 mL of 0.1 M phosphate buffer 
solution (pH 7.4) and then 0.2 mL of hydrogen peroxide solution were added. The absorbance of 
the reaction mixture was measured at 230 nm after 10 min. The reaction mixture without sample 
was used as blank. Sample blank was also prepared without reagents. Ascorbic acid was used as 
standard. The percentage inhibition of hydrogen peroxide was calculated using the formula,  
 
              % inhibition = [(Control–Test) / Control] × 100  
The concentration of the sample required for 50 % reduction in absorbance  (IC50) was calculated 
using linear regression analysis.  
The results are tabulated in Table: 25 and the calibration graph was presented in Figure: 
24&25. 
DETERMINATION OF REDUCING POWER ASSAY (Navnath et al.,2010) 
Principle 
Reducing power assay is a spectrophotometric method and is based on the principle that 
increases absorbance of the reaction mixture indicates the increase in the reducing power of the 
sample. Antioxidant activity may be due to a variety of mechanism viz., the prevention of chain 
initiation, the binding of transition metal ion catalysts, decomposition of peroxides, the reducing 
capacity and free radical scavenging. The assay is based on the reduction of ferric in potassium 
ferricyanide to ferrous to form potassium ferrocyanide by the sample and the subsequent 
formation of Prussian blue colour with ferric chloride. The absorbance of the blue complex is 
measured at 700 nm.  
Potassium ferricyanide+ Ferric chloride 
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 Antioxidant 
 
Potassium ferrocyanide + Ferrous chloride 
Instrument 
UV Visible spectrophotometer, Shimadzu (Model 1800). 
Materials required 
• Ascorbic acid   
• 1 % w/v Potassium ferricyanide 
• 10 % w/v Trichloro acetic acid   
• 0.2 M, Phosphate buffer (pH 6.6)   
• 0.1% w/v Ferric chloride   
Procedure 
The reducing power ability of plant extracts was screened by assessing the ability of the 
test extract to reduce FeCl3 solution as mentioned by Oyaizu et al., (1986). 0.1 to 0.5 mL of plant 
extract solution (1 mg/mL) was mixed with 0.75 mL of phosphate buffer and 0.75 mL of 1 % 
potassium ferricyanide [K3Fe (CN6)] and incubated at 50
oC for 20min. About 0.75 mL of 10 % 
trichloro acetic acid was added to the mixture and allowed to stand for 10min. The whole 
mixture was then centrifuged at 3000 rpm for 10min. Finally 1.5 mL of the supernatant was 
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removed and mixed with 1.5 mL of distilled water and 0.1mL of 0.1 % ferric chloride solution 
and the absorbance was measured at 700 nm in UV-Visible Spectrophotometer. Ascorbic acid 
was used as standard and phosphate buffer was used as blank solution. The results are tabulated 
in Table: 26 and the calibration graph was presented in Figure: 26&27. 
DETERMINATION OF TOTAL ANTIOXIDANT ACTIVITY (Prieto et al., 1999)  
Principle 
The total antioxidant activity of the extract was evaluated by phosphomolybdenum 
method. The assay is based on the reduction of Mo (VI) to Mo (V) by the sample and by the 
subsequent formation of green phosphate Mo (V) complex at acidic pH which has a maximum 
absorption at 695 nm. This method is routinely used to determine total antioxidant activity of 
samples.  
Mo6+→   Mo5+ 
Instrument 
UV Visible spectrophotometer, Shimadzu (Model) 1800. 
Reagents 
• 0.6M sulphuric acid   
• 28mM sodium phosphate   
• 4mM ammonium molybdate 
Procedure 
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An aliquot of 0.3 mL of different concentrations of sample was treated with 2.7 mL of 
the reagent (H2SO4, sodium phosphate and ammonium molybdate). In case of blank, 0.3 mL of 
methanol was used in place of sample. The tubes were incubated in a boiling water bath at 95°C 
for 90 min. The samples were cooled to room temperature, the absorbance of the aqueous 
solution of each concentration was measured at 695 nm against blank. The standard vitamin C 
was treated in a similar manner. The antioxidant activity was expressed as equivalents of 
Vitamin C (µg/mL). The results are tabulated in Table: 27 and the calibration graph was 
presented in Fig: 28&29.  
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RESULTS AND DISCUSSION 
MACROSCOPICAL STUDIES 
Fresh leaves of commelinabenghalensis.L was subjected to macroscopical studies and the results 
are presented in Table:1. 
Table:1 Macroscopical  studies of  Commelinabenghalensis.L(Leaf). 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
S.NO PARAMETERS OBSERVATION 
1 Colour/surface  
 Outer 
Inner 
Dull green 
Pale green 
2 Odour No characteristic 
3 Taste Mucilaginous 
4 Type Simple 
5 Shape Ovate 
6 Phyllotaxy Alternate 
7 Apex Acute 
8 Base Unequal 
9 Stipules Present 
10 Margin Entire 
11 Venation Parallel 
12 Surface Sheathing 
13 Length 2.8-7.6 cm 
14 Width 1.9-3.1 cm 
15 Petiole length 0.8-2.3 cm 
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Macroscopical studies of Commelinabenghalensis.Lrevealed the outer surface showed 
dull green and the inner surface showed pale green with mucilaginous taste and odourless. The 
leaves are simple, ovate shape with acute apex, unequal base with stipules.The leaves are entire 
margin, parallel venation with alternate arrangement, surface sheathing. The leaves are of 2.8-7.6 
cm in length and 1.9-3.1 cm width and its petiole length 0.8-2.3 cm.  
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Figure:1 Habitat of Commelina Benghalensis L. 
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Figure: 2 Macroscopy of Commelina benghalensis L. (Leaf) ( Dorsal view ) 
 
Figure: 3 Macroscopy of Commelina benghalensis L. (Leaf) ( Ventral view ) 
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Figure: 4 Macroscopy of Flowers of Commelina benghalensis L. 
 
Figure: 5 Stipules of Commelina benghalensis L. 
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MICROSCOPICAL STUDIES 
Figure: 6 Transverse Section of Leaves 
 
Figure: 7 Transverse Section of Midrib Enlarged 
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Figure: 8 Transverse Section of Leaf Sheath – Meristem Region 
 
Figure: 9 Transverse Section of Shoot Tip – Meristem Region  
 
Figure: 10 Transverse Section of Lamina Enlarged 
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Figure: 11  Hexacytic stomata of Commelina benghalensis L. 
 
 
 
Figure: 12 Non Glandular Trichomes of Commelina benghalensis L. 
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Figure: 13 Powder microscopy of Commelina benghalensis L. 
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MICROSCOPICAL STUDIES 
TRANSVERSE SECTION OF LEAF 
Epidermis 
Transverse section of Commelinabenghalensis L.leaves consists of an upper epidermis 
and lower epidermis. The epidermal cells are polygonal in shape.  
Stomata 
Amphistomatic types of stomata were present on both surfaces and abaxial side of the 
epidermis is more frequently. Hexacytic type of stomata were present. 
Trichomes 
The presence of simple bicellular hooked non glandular trichomes on both surface of 
leaves.  
Ground Tissue 
The ground tissue system of leaf is known as mesophyll tissue. The presences of 
mesophyll tissue have lot of air spaces. Stone cells of astrosclereids and osteosclereids were 
present in the mesophyll tissue. Crystals and starch grains are present in the mesophyll tissue.  
Vascular Bundles 
The vascular bundles are collateral and closed. Kidney shaped, Xylem vessels and 
trachids are also present in the vascular bundle. 
TRANSVERSE SECTION OF MIDRIB ENLARGED 
Epidermis 
Transverse section of Commelinabenghalensis L.leaves consists of an upper epidermis 
and lower epidermis. The epidermal cells are polygonal in shape.  
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Trichomes 
The presence of simple bicellular hooked non glandular trichomes on both surface of 
leaves.  
Ground Tissue 
The ground tissue system of leaf is known as mesophyll tissue. The presences of 
mesophyll tissue have lot of air spaces. Stone cells of astrosclereids and osteosclereids were 
present in the mesophyll tissue. Crystals and starch grains are present in the mesophyll tissue.  
Vascular Bundles 
The vascular bundles are collateral and closed. Kidney shaped, Xylem vessels and 
trachids are also present in the vascular bundle. 
TRANSVERSE SECTION OF LEAF SHEATH – MERISTEM REGION 
Transverse section of Commelinabenghalensis L. leaf sheath shows outer covering 
sheath. Circinate venation circle of young leaves present in meristem region.  
Vascular Bundles 
Vascular bundles are collateral and closed. Vascular bundles consist of xylem and 
phloem. Outer covering sheath also consists of vascular bundles. 
TRANSVERSE SECTION OF SHOOT TIP – MERISTEM REGION  
Transverse section of Commelinabenghalensis L. leaf shoot tip shows Circinate venation 
circle of young leaves. Vascular bundles are collateral and closed. Vascular bundle consists of 
xylem and phloem. 
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TRANSVERSE SECTION OF LAMINA & LAMINA ENLARGED 
Transverse section of Commelinabenghalensis L. lamina consists of upper epidermis and 
lower epidermis. Palisade tissue and mesophyll tissue presented in the lamina.   
QUANTITATIVE MICROSCOPY OF CommelinaBenghalensis L. LEAVES 
 Fresh leaves of Commelinabenghalensis L. was subjected to microscopical studies 
includes in stomatal number, stomatal index were determined and the results are showed in 
Table: 2 
Table: 2 Quantitative Microscopy of Commelinabenghalensis L.Leaves 
 
 
S.NO Parameters Minimum 
 
(per mm2) 
Average 
 
(per mm2) 
Maximum 
 
(per mm2) 
1 Stomatal Number 
  Lower Epidermis 
 
 
  Upper Epidermis 
 
39 
 
 
15 
 
48 
 
 
20 
 
42.6 
 
 
17.8 
2 Stomatal Index 
Lower Epidermis 
 
 
Upper Epidermis 
 
30.7 
 
 
13.8 
 
34.5 
 
 
20.8 
 
32.0 
 
 
17.32 
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Determination of Physio – Chemical constants of Commelinabenghalensis L. (Leaf) 
The powder was subjected to physiochemical parameters such as foreign organic matter, 
loss on drying, ash values and extractive values with different solvents in increasing order of 
polarity, volatile oil, and total solids and the results are showed in Table: 3 
 
Table:3 Determination of Physio – Chemical Constants of Commelinabenghalensis L. (Leaf) 
S.NO PHYSIO – CHEMICAL 
CONSTANTS 
REPORTS 
1 Foreign matter Nil 
2 Loss on drying 0.78 ± 0.11% w/w 
3 Total solids 99.22 ± 0.11 % w/w 
4 Bitterness value Nil 
5 Volatile oil content Nil 
6 Petroleum ether extractive 0.6  ± 0.12% w/w 
7 Ethyl acetate extractive 1.6  ± 0.12% w/w 
8 Chloroform extractive 1.7  ± 0.07% w/w 
9 Methanol extractive 4.4  ± 1.29% w/w 
10 Aqueous extractive 12.13  ± 1.30% w/w 
11 Total ash 16 % w/w 
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12 Water soluble ash 10.5 % w/w 
13 Acid insoluble ash 1.17 % w/w 
 
Physio – chemical constants of Commelinabenghalensis L. (Leaf – crude powder) was 
found to be, Loss on drying (0.78 ± 0.11% w/w), Total Solids (99.22 ± 0.11 % w/w). The 
powder did not possess any foreign matter, bitter principle and volatile oil content. The powder 
also exhibits Petroleum ether extractive value (0.6 ± 0.12% w/w), Ethyl acetate extractive values 
(1.6 ± 0.12%  w/w), Chloroform extractive value (1.7  ± 0.07% w/w), Methanol extractive values 
(4.4  ± 1.29% w/w), Aqueous extractive values (12.13  ± 1.30% w/w), Total ash value (16 % 
w/w), Water soluble ash value (10.5 % w/w), Acid insoluble ash value (1.17 % w/w) 
Behavioural characters of the Commelinabenghalensis L. (Leaf – crude powder) with 
different reagents.  
  Crude powder of leaf was treated with various reagent and the results are showed in Table: 4 
Table:4 Behavioural characters of the Commelinabenghalensis L. (Leaf – crude powder) 
with different reagents.  
Crude powder of 
Commelinabenghalensis L. 
(Leaf) 
Visible light UV Light 
(254 nm) 
UV Light 
(365 nm) 
Powder + water Black  Brown Did not show any 
characteristic change 
Power + Con.HCL Black  Brown Did not show any 
characteristic change 
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Powder + Con.H2SO4 Black  Dull brown Did not show any 
characteristic change 
Powder + Con.HNO3 Yellow  Green Did not show any 
characteristic change 
Powder + CH3COOH Black  Dull green Did not show any 
characteristic change 
Powder + Con.HCL + Water Black  Dull green Did not show any 
characteristic change 
Powder  
+ Con.H2SO4 + Water 
Black  Dull green Did not show any 
characteristic change 
Powder + Con.HNO3 + Water Yellow  Dull green Did not show any 
characteristic change 
Powder + CH3COOH + Water Yellowish brown Dull green Did not show any 
characteristic change 
Powder + Aqueous NaOH Black Dull green Did not show any 
characteristic change 
Powder + Aqueous FeCl3 Black Dull green Did not show any 
characteristic change 
 
Crude powder when treated with Water, Con.HCl, Con H2SO4, CH3COOH, Con HCl + 
Water, Con H2SO4 + Water and Aqueous NaOH, Aqueous Fecl3 showed black colour in visible 
light. Powder treated with Con.HNO3 and Con.HNO3 + Water showed yellow colour in visible 
light. Powder treated with CH3COOH + Water showed yellowish brown colour in visible light. 
Powder when treated with Water and Con.HCl showed brown colour in UV 254 nm. Powder 
treated with Con.H2SO4 showed dull brown colour in UV 254 nm. Powder treated with 
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Con.HNO3 showed green colour in UV 254 nm. Powder when treated with CH3COOOH, 
Con.HCl + Water, Con.H2SO4 + Water, Con.HNO3 + Water, CH3COOH + Water, Aqueous 
NaOH, Aqueous Fecl3 showed dull green colour in UV 254 nm. The powder did not show any 
characteristic colour change with the reagent under UV 366 nm.   
 Determination of physical parameters of (HAECB) 
  Hydro alcoholic extract of Commelinabenghalensis L. was subjected to physical 
parameter such as weight/ml, refractive index, consistency, colour and the results are displayed 
in Table: 5 
Table:5   Determination of physical parameters of (HAECB) 
S.NO PARAMETERS REPORTS 
1 Refractive Index 1.342 ± 0.002 
2 Weight/ml 0.882 ± 0.010 
3 Consistency Semi solid 
4 Colour Dark Brown 
 
  The physical parameters of hydro alcoholic extracts of Commelinabenghalensis L. (Leaf) 
such as refractive index, weight per ml, consistency and colour was determined. It was found to 
be refractive index (1.342 ± 0.002), weight per ml (0.882 ± 0.010), dark brown in colour with 
semisolid consistency. 
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Preliminary phytochemical screening of Aqueous and Hydro – Alcoholic extract of  
Commelinabenghalensis L. (Leaf) 
Hydroalcoholic extract of Commelinabenghalensis L. (Leaf) was subjected to qualitative 
chemical analysis. The various chemical tests were performed on this extract and aqueous extract 
for the identification of phytochemicals, secondary metabolites and the results are displayed in 
Table: 6 
Table: 6 Preliminary phytochemical screening of Aqueous and Hydro – Alcoholic extract 
of  Commelinabenghalensis L. (Leaf) 
S.NO Test Hydroalcoholic extract 
of 
Commelinabenghalensis 
L. (Leaf) 
Aqueous extract of 
Commelinabenghalensis 
L. (Leaf) 
1 Alkaloids  
 
Mayer’ Test Positive Positive 
 
Dragendorff’s Reagent Negative Negative 
 
Hager’s Reagent Positive Positive 
 
Wagner’s Reagent Positive Positive 
2 Carbohydrates  
 Benedict’s Test Positive Positive 
 Fehling’s Test Positive Positive 
 Molisch’s Test Positive Negative 
3 Anthraquinone Glycoside  
 Borntrager’s Test Negative Negative 
 Modified Borntrager’s Test Negative Negative 
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4 Cardiac Glycosides  
 Keller killiani Test Negative Negative 
 Legal Test Negative Negative 
5 Sterols  
 Salkowski’s Test Positive Positive 
 Libbermann-Burchard’s Test Negative Negative 
6 Saponins Positive Positive 
7 Tannins and Phenolic 
compounds 
 
 Folinciocalteu’s phenol Reagent Positive Positive 
 Fecl3 Test  Positive Positive 
8 Flavonoids  
 Shinoda Test Positive Positive 
 Lead Acetate Test Positive Positive 
 Acid Test Positive Positive 
 Alkali Test Positive Positive 
9 Protein and Free Amino Acids  
 Biuret Test Positive Negative 
 Ninhydrin Test Positive Positive 
 Sulphur containing Amino Acid Positive Positive 
10 Mucilage Positive Positive 
11 Quinone Positive Positive 
12 Phlobatannins Positive Positive 
13 Carotenoids Positive Positive 
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14 Terpenoids Positive Negative 
15 Betacyanins Positive Negative 
16 Emodin Negative Positive 
17 Fixed oil Negative Negative 
18 Gum Negative Negative 
19 Anthocyanins Negative Negative 
20 Lecoanthocyanins Negative Negative 
21 Resins Negative Negative 
22  Volatile oil Negative Negative 
 
The phytochemical screening of the hydroalcoholic extract (70%) of 
Commelinabenghalensis L. (Leaf) powder revealed the presence of alkaloids, carbohydrates, 
sterols, saponins, tannins and phenolic compound, flavonoids, protein and free aminoacid, 
terpenoids, mucilage, betacyanin, quinone, phlobatannins, carotenoids. It shows the absence of 
anthraquinone glycosides, cardiac glycoside, fixed oil, anthocyanin, lecoanthocyanin, volatile 
oil,emodin, gum, resins,. The aqueous extract of Commelinabenghalensis L. (Leaf) powder 
revealed the presence of alkaloids, carbohydrates, sterols, saponins, tannins and phenolic 
compound, flavonoids, protein and free aminoacid, mucilage, emodin, quinone, phlobatannins, 
carotenoids. It shows the absence of anthraquinone glycosides, cardiac glycoside, terpenoids, 
fixed oil, betacyanin, gum, anthocyanin, lecoanthocyanin, resins, volatile oil. 
THIN LAYER CHROMATOGRAPHY PROFILE  
 Hydro alcoholic extract of Commelinabenghalensis L. was subjected to TLC by using 
different mobile phases to identify the Rf value and the results are presented in Table: 7 
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Table:7 TLC PROFILE OF HAECB 
S.NO Mobile Phase Rf Value Detection Spot 
colour 
Report 
Standard HAECB 
1 
 
 
 
 
 
 
Acetic acid : 
Chloroform 
(1:9) 
 
Gallic acid 
0.25 
 
 
HAECB 
0.25 
 
0.90 
 
Folin 
Reagent 
 
 
Blue 
colour 
 
May indicate 
the presence of 
Phenolic 
compound 
2 Ethyl Acetate 
: Benzene 
(9:11) 
Gallic acid 
0.72 
HAECB 
0.73 
0.96 
Folin 
Reagent 
 
Blue 
colour 
 
May indicate 
the presence of 
Phenolic 
compound 
3 Chloroform : 
Ethyl Acetate 
(60:40) 
Rutin 
0.46 
HAECB 
0.71 
Visible 
light 
Yellow May indicate 
the presence of 
Flavonoids, 
Flavones, 
Flavonols 
4 Ethyl Acetate 
: Formic Acid 
: Glacial 
Acetic Acid : 
Water 
 (100 : 11 : 11: 
26) 
Rutin 
0.42 
HAECB 
0.45 
0.93 
0.97 
Visible 
light 
Orange 
Yellowish 
green 
Yellow 
May indicate 
the presence of 
Flavonoids, 
Flavones, 
Flavonols 
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Thinlayer chromatography of the hydroalcoholic extract of Commelinabenghalensis L. 
(Leaf) showed the Rf value 0.25(Gallic acid standard) 0.25, 0.90(sample) may indicate the 
presence of phenolic compounds the solvent system used in Acetic acid : Chloroform (1:9). Rf 
value 0.72 (Gallic acid standard), 0.73,0.90 (sample) may indicate the presence of phenolic 
compounds the solvent system used in Ethyl acetate : Benzene (9:11). Rf value 0.46 (Rutin 
standard) 0.71, may indicate the presence of flavonoids the solvent system used in Chloroform : 
Ethyl Acetate (60:40). Rf value 0.42 (Rutin standard), 0.45,0.93,0.97 may indicate the presence 
of flavonoids, flavones, flavonols the solvent system used in Ethyl Acetate : Formic Acid : 
Glacial Acetic Acid : Water (100:11:11:26). 
QUANTITATIVE ANALYSIS 
Quantitative analysis includes estimation of total gallic acid, total tannin, total flavonoid 
contents in terms of total gallic acid equivalent, total tannic acid equivalent, total flavonoids 
equivalent (rutin). In addition total carotenoid and total chlorophyll content were determined for 
the fresh leaf and were dispalyed in seperateTables. 
 
DETERMINATION OF GALLIC ACID EQUIVALENT IN (HAECB) 
Hydroalcoholic extract of Commelinabenghalensis L. was found tocontain 112 mg/g of 
GAE and the standard curve of gallic acid and its results were displayed in Table: 8 and Figure: 
14.  
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Figure: 14 Standard Curve of Gallic Acid 
 
Table: 8 Determination of Gallic Acid Equivalent in (HAECB) 
Sl.no Concentration 
 
Gallic Acid HAECB  
    (µg/ml)         (µg/ml)      
Absorbance 
 
Gallic Acid          HAECB 
 
*Mean   ±   SEM *Mean   ±  SEM  
Amount of Gallic 
Acid equivalent 
(GAE) in 
(HAECB) 
(µg/ml) 
1  5                      10 0.0577 ± 0.008     0.0067 ± 0.0006 1.06 
2 10             20 0.095  ± 0.00110.0163 ± 0.0008 1.94 
3 15             30 0.1677 ±0.00080.0357 ± 0.0008 3.7 
4 20 0.1753 ± 0.0008  
5 25 0.3023 ± 0.0008  
                                          GAE 112 mg/g 
*mean ± SEM 
 
Hydroalcoholic extract of Commelinabenghalensis L.was found tocontain112 mg/g of GAE and 
the standard curve ofgallic acid and its results were displayed in Table: 8 and Figure: 14. 
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DETERMINATION OF TANNIC ACID EQUIVALLENT IN HAECB 
Hydroalcoholic extract of Commelinabenghalensis L. was found tocontain 198 mg/g of TAE and 
the standard curve of tannic acid and its results were displayed in Table: 9 and Figure: 15. 
Figure: 15 Standard Curve of Tannic Acid 
 
Table: 9 Determination of Tannic Acid Equivallent in HAECB 
*mean ± SEM 
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ABSORBANCE
Sl. No Concentration 
 
Tannic Acid HAECB 
    (µg/ml)        (µg/ml)                 
Absorbance 
 
Tannic Acid          HAECB 
*Mean   ±   SEM *Mean   ±  SEM  
Amount of Tannic 
Acid equivalent 
(TAE) in 
(HAECB) 
(µg/ml) 
1  5                      10 0.0423 ± 0.00080.0033 ± 0.0003 1.81 
2 10             20 0.0537 ± 0.00080.012   ± 0.0005 2.78 
3 15             30 0.1123 ± 0.00080.0527 ± 0.0008 7.3 
4 20 0.1593 ± 0.0008  
5 25 0.2383 ± 0.0008  
                                                                                                    TAE 198 mg/g 
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Hydroalcoholic extract of Commelinabenghalensis L. was found tocontain 198 mg/g of 
TAE and the standard curve of tannic acid and its results were displayed in Table: 9 and 
Figure: 15.  
 
DETERMINATION OF RUTIN EQUIVALLENT IN HAECB 
Hydroalcoholic extract of Commelinabenghalensis L. was found tocontain 989 mg/g of 
RE and the standard curve of rutin and its results were displayed in Table: 10 and Figure: 16. 
Figure: 16 Standard Curve of Rutin 
 
 
 
 
 
 
 
0
0,02
0,04
0,06
0,08
0,1
0 5 10 15 20 25 30
A
b
so
rb
a
n
ce
 
concentration (µg/ml) 
Standard curve of Rutin 
ABSORBANCE
                                                                             RESULTS AND DISCUSSION 
 
DEPT. OF PHARMACOGNOSY, COP, MMC, MADURAI-20 Page 92 
 
Table: 10 Determination of RutinEquivallent in HAECB 
*mean ± SEM 
Hydroalcoholic extract of Commelinabenghalensis L. was found tocontain 989 mg/g of 
RE and the standard curve of rutin and its results were displayed in Table: 10 and Figure: 16. 
Determination of Chlorophyll “a”, Chlorophyll “b”, Total Chlorophyll and Total 
Carotenoid 
Table: 11 Determination of Chlorophyll “a”, Chlorophyll “b”, Total Chlorophyll and Total 
Carotenoid  
S.No Wavelength Absorbance 
1 645 0.019 
2 663 0.028 
3 453 0.212 
 
Sl.no Concentration 
 
Rutin             HAECB  
(µg/ml)            (µg/ml)    
Absorbance 
 
Rutin          HAECB 
 
*Mean   ±   SEM *Mean   ±  SEM  
Amount of Rutin 
equivalent (RE) in 
(HAECB) 
(µg/ml) 
1  5                      10 0.0187 ± 0.00060.0267 ± 0.0006 9.57 
2 10             20 0.0287 ± 0.00030.0583 ± 0.0008 20.1 
3       15  0.0473 ± 0.0008  
4 20 0.0573 ± 0.0012  
5 25 0.0933 ± 0.0008  
                                 RE 989 mg/g 
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                                                                       12.7 × O.D at 663 nm – 2.69 × O.D at 645 
Chlorophyll “a” (mg/g fresh tissue) =                                     1000 × 0.05 
 
 
   22.9 × O.D at 645 nm – 4.68 × O.D at 663 × 10Chlorophyll “b” (mg/g 
fresh tissue) =                                      1000 × 0.05 
 
 
     20.2 × O.D at 645 nm + 8.02 × O.D at 663 × 
10Totalchlorophyll (mg/g fresh tissue) =                                       1000 × 0.05 
 
 
Total carotenoid (mg/g fresh tissue) =    0.216 × O.D 663 – 1.22 × O.D 645 – 0.354 × O.D at 663 + O.452 × O.D 453 
Table:12Amount of Chlorophyll “a”, Chlorophyll “b”, Total Chlorophyll and Total Carotenoid  
Sl.no Components Amount 
1 Chlorophyll a 0.00311 mg/gm 
2 Chlorophyll b 0.017506 mg/gm 
3 Total chlorophyll 0.052588 mg/gm 
4 Total carotenoid 0.06878 mg/gm 
ISOLATON OF LUTEIN  
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 Lutein was isolated by using diethyl ether and methanol followed by saponification 
process. 
UV  SPECTRAL STUDIES 
 Isolated compound was subjected to UV spectral studies for identification of compounds 
UV  SPECTRAL STUDIES  
Lutein and Chlorophyll 
 Aliquot of crude extract was transferred to cuvette (quartz) and was scanned under UV 
range from 300 – 700 nm in the UV – Visible spectrophotometer to check the presence of 
chlorophyll and lutein. It shows the absorbance maxima at 665, 466, 412 nm. It indicates the 
presence of chlorophyll (665 nm) and lutein (466, 412 nm)  
 
Figure: 17   UVSpectrum  of Lutein and Chlorophyll 
Table: 13 UV Absorbanceof  proposedlutein and chlorophyll 
nm.
300.00 400.00 500.00 600.00 700.00 800.00
A
b
s
.
2.956
2.000
1.000
0.000
1
2
3
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Sl. No WAVELENGTH (nm) MAXIMUM ABSORBANCE MAXIMA 
1 665 1.274 
2 466 1.417 
3 412 2.689 
 
UV spectral studies (Shimadzu 1800) 
LUTEIN 
 The isolated compound lutein was dissolved in diethyl ether and transferred to cuvette 
(quartz) and was scanned under UV range from 300 – 700 nm in the UV – Visible 
spectrophotometer. The isolated compound lutein shows absorbance maxima at 470, 444 nm. 
 
Figure: 18 UV Spectrum of Proposed Lutein 
 
Table: 14 UV Absorbance of proposed lutein 
nm.
300.00 400.00 500.00 600.00 700.00 800.00
A
b
s
.
1.882
1.500
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0.500
0.000
1
2
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Sl.no WAVELENGTH (nm) MAXIMUM ABSORBANCE MAXIMA 
1 470 1.392 
2 444 1.712 
 
1H NMR SPECTRUM OF PROPOSED LUTEIN 
The Isolated compound was dissolved in Deuterated chloroform (CDCL3) and the NMR 
spectrum was obtained by using UXNMR BrukerAnalytischeMesstechnikGmbh.  
1H NMR 
 
 
Figure: 19   1H Nmr Spectrum of Proposed Lutein 
 
Chemical shift values. 
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1H NMR: (300 MHz, CDCl3) δH  0.78( s, 10H), 0.94 - 1.00 (bd, 2H), 1.12 - 1.35 (bm, 
21H), 1.53-1.60 (bd, 3H), 1.81-1.90 (bd, 8H), 3.38-3.45 (m, 2H), 4.73 (s, 1H). 
 
Table: 15 Observed chemical shift value of1H NMR 
Sl.No δvalue Band name Position of hydrogen atom 
1 0.78 s 10H 
2 0.94 - 1.00 bd 2H 
3 1.12 - 1.35 bm 21H 
4 1.53-1.60 bd 3H 
5 1.81-1.90 bd 8H 
6 3.38-3.45 m 2H 
7  7 4.73 s 1H 
  
Table: 16Reported chemical shift value of1H NMR 
Sl.No δvalue Band name Position of hydrogen atom 
1 0.998 s 6H 
2 1.074 S 6H 
3 1.37 Dd 1H 
4 1.626 S 3H 
5 1.739 S 3H 
6 1.84 dd 1H 
7 1.912 s 3H 
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8 1.970 s 9H 
9 2.33-2.45 m 2H 
10 4.0 m 1H 
 
13C NMR SPECTRUM OF PROPOSED LUTEIN 
The Isolated compound was dissolved in Duterated chloroform (CDCL3) and the NMR 
spectrum was obtained by using UXNMR BrukerAnalytischeMesstechnikGmbh.  
13C NMR 
 
Figure: 20      13C NMR Spectrum of  Proposed Lutein 
Chemical shift values. 
13C NMR: (75 MHz, CDCl3); δC 15.3, 19.7, 19.9, 22.6, 22.7, 24.8, 25.2, 28.0, 29.7, 31.9, 
32.7, 32.8, 36.7, 37.3, 37.5, 38.4, 65.9, 130.3. 
Table: 17 CHEMICAL SHIFT VALUE OF 13C NMR  
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Sl.No 
CHEMICAL SHIFT VALUE 
OF 13C NMR OBSERVED 
CHEMICAL SHIFT VALUE OF 13C 
NMR REPORTED 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
15.3 
19.7 
19.9 
22.6 
22.7 
24.8 
25.2 
28.0 
29.7 
31.9 
32.7 
32.8 
36.7 
37.3 
37.5 
38.4 
65.9 
130.3 
13.2 
21.6 
22.8 
24.3 
28.7 
29.5 
30.2 
34.0 
37.1 
65.9 
130.0 
 
 
 
 
 
 
 
GC-MS STUDIES 
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 The isolated compound was subjected to GC-MS studies and the spectrum was obtained 
by using bruker instrument. 
GC-MS PROFILE OF PROPOSED LUTEIN 
Figure: 21 GC-MS Profile of Proposed Lutein 
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Figure: 21.1 GC-MS Profile of Proposed Lutein 
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GC-MS PROFILE 
 
 
 
 
Figure: 21.2 GC-MS Profile of Proposed Lutein 
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PEAK 1
 
 
Figure:21.3 GC-MS profile of proposed lutein 
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PEAK 2 
 
 
 
Figure: 21.4 GC-MS profile of proposed lutein 
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PEAK 3 
 
 
Figure: 21.5 GC-MS profile of proposed lutein 
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PEAK 4 
 
 
 
Figure: 21.6 GC-MS profile of proposed lutein 
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PEAK 5 
 
 
Figure: 21.7 GC-MS profile of proposed lutein 
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PEAK 6 
 
 
 
Figure: 21.8 GC-MS profile of proposed lutein 
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PEAK 7 
 
 
Figure: 21.9 GC-MS profile of proposed lutein 
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PEAK 8 
 
 
Figure: 21.10 GC-MS profile of proposed lutein 
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PEAK 9 
 
 
 
Figure: 21.11 GC-MS profile of proposed lutein 
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PEAK 10 
 
 
Figure: 21.12 GC-MS profile of proposed lutein 
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PEAK 11 
 
Figure: 21.13 GC-MS profile of proposed lutein 
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PEAK 12 
 
 
Figure: 21.14 GC-MS profile of proposed lutein 
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PEAK 13 
 
 
 
Figure:21.15  GC-MS profile of proposed lutein 
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PEAK 14 
 
 
 
Figure: 21.16 GC-MS profile of proposed lutein 
 
 
 
 
                                                                             RESULTS AND DISCUSSION 
 
DEPT. OF PHARMACOGNOSY, COP, MMC, MADURAI-20 Page 117 
 
 
 
 
PEAK 15 
 
 
 
Figure:21.17  GC-MS profile of proposed lutein 
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PEAK 16 
 
 
Figure: 21.18 GC-MS profile of proposed lutein 
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PEAK 17 
 
 
Figure: 21.19 GC-MS profile of proposed lutein 
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PEAK 18 
 
 
 
Figure: 21.20 GC-MS profile of proposed lutein 
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PEAK 19 
 
 
 
Figure: 21.21 GC-MS profile of proposed lutein 
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PEAK 20 
 
 
 
Figure: 21.22 GC-MS profile of proposed lutein 
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PEAK 21 
 
 
 
 
Figure: 21.23 GC-MS profile of proposed lutein 
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PEAK 22 
 
 
 
 
Figure: 21.24 GC-MS profile of proposed lutein 
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STRUCTURE OF LUTEIN 
 
 
 
IUPAC NAME:β,ε-carotene-3,3'-diol 
Other name 
4-[18-(4-Hydroxy-2,6,6-trimethyl-1-cyclohexenyl)-3,7,12,16-tetramethyloctadeca 
1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethyl-cyclohex-2-en-1-olXanthophyll 
 
Chemical formula : C40H56O2 
Appearance  : Red – orange crystalline solid 
Solubility in water : Insoluble 
Solubility in fats : Soluble 
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Table: 18 GC-MS ANALYSIS OF PROPOSED LUTEIN 
 
Sl.No Peak No Retention Time 
   (minutes) 
Molecular Weight Name of the compound 
1 1 8.654 124 3-Octyne, 7-methyl- 
2 2 9.091 128 Naphthalene 
3 3 11.645 212 Pentadecane 
4 4 14.919 184 Tridecane 
5 5 18.275 220 ButylatedHydroxy Toluene 
6 6 21.683 212 Pentadecane 
7 7 23.775 262 Sulfurous acid, cyclohexylmethyl 
hexyl ester 
8 8 24.212 296 Heptadecane, 2,6,10,15-
tetramethyl- 
9 9 25.388 272 Methoxyacetic acid, 3-tridecyl 
ester 
10 10 26.731 296 1-Iodo-2-methylundecane 
11 11 27.717 268 2-Pentadecanone, 6,10,14-
trimethyl- 
12 12 29.507 284 Hexadecanoic acid, 15-methyl-, 
methyl ester 
13 13 30.106 278 Dibutyl phthalate 
14 14 30.872 340 Eicosanoic acid, ethyl ester 
15 15 31.153 256 n-Hexadecanoic acid 
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16 16 32.672 326 Hexadecanoic acid, 3,7,11,15-
tetramethyl-, methyl ester 
17 17 33.307 296 Phytol 
18 18 33.630 294 1-Hexadecyn-3-ol, 3,7,11,15-
tetramethyl- 
19 19 34.155 266 9-Octadecenal 
20 20 34.589 394 Cyclopropanetetradecanoic 
acid, 2-octyl-, methyl ester 
21 21 36.260 242 1-Hexadecanol 
22 22 39.542 414 Heptacosane, 1-chloro- 
 
 Some of the peaks were relevant with molecular weight in the GC-MS 
profile(Figure: 21-21.24), identified the presence of certain linkages of lutein.Hence the derived 
Ultraviolet spectrum(Table 13&14), Nuclear Magnetic Resonance (1H NMR, 13C NMR) 
spectrum(Table15,16&17) and GC-MS profile(Table:18) confirmed the molecular weight of 
lutein and also supports the additional research work indicating the chemical structure of lutein 
from the leaf powder. (Omayma A. Eldahshan et al., 2013 &Finar IL, 1975) 
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DETERMINATION OF SUN PROTECTION FACTOR OF ISOLATED LUTEIN FROM 
Commelinabenghalensis L. 
 Isolated compound lutein was subjected to sun protection factor determination and the 
results are showed in Table: 20, 21 & 22. 
SUN PROTECTION FACTOR 
Table: 19 Values of EE * I used in the calculation of SPF 
Wavelength ( λ nm) EE * I (Normalized) 
290 0.0150 
295 0.0817 
300 0.2874 
305 0.3278 
310 0.1864 
315 0.0839 
320 0.0180 
Total 1 
 
EE – Erythemal effect spectrum , I – solar intensity spectrum 
SPF can be calculated by applying the following formula known as Mansur equation 
(Kaur and Saraf, 2010; Mishra et al., 2012): 
 SPF = CF ×∑  𝐄𝐄 ሺ𝛌ሻ  ×  𝐈 ሺ𝛌ሻ  ×  𝐀𝐛𝐬 ሺ𝛌ሻ  ଷଶ0ଶ90  
 
                                                                             RESULTS AND DISCUSSION 
 
DEPT. OF PHARMACOGNOSY, COP, MMC, MADURAI-20 Page 129 
 
 
Where CF = correction factor (10), EE (λ) = erythmogeniceffect of radiation with wavelength λ, 
Abs (λ) =Spectrophotometric absorbance values at wavelength λ. The values of EE x λ are 
constants. 
 
DETERMINATION OF SUN PROTECTION FACTOR OF ISOLATED LUTEIN FROM 
Commelinabenghalensis L. (LUTEIN 50,100,200 µg/ml) 
Table: 20Lutein 50 µg/ml 
Sl.no     Wavelength ( λ nm )      EE * I 
(Normalized)  
   Absorbance 
(Lutein 50µg/ml) 
Mean ± SEM 
   SPF value 
1 290 0.0150 0.119 ± 0.0017 0.01785 
2 295 0.0817 0.115 ± 0.0003 0.093955 
3 300 0.2874 0.116 ± 0.0003 0.333384 
4 305 0.3278 0.113 ± 0.0003 0.370414 
5 310 0.1864 0.114 ±0.0006 0.212496 
6 315 0.0839 0.119 ± 0.0003 0.099841 
7 320 0.0180 0.122 ± 0.0003 0.02196 
   SPF 1.1499 ± 0.43 
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Table: 21Lutein 100 µg/ml 
Sl.no   Wavelength (λ nm )      EE * I 
(Normalized)  
Absorbance 
Lutein (100 µg/ml) 
Mean ± SEM 
 
SPF value 
1 290 0.0150 0.241 ± 0.0003 0.03615 
2 295 0.0817 0.241 ± 0.0003 0.196897 
3 300 0.2874 0.238 ± 0.0003 0.684012 
4 305 0.3278 0.234 ± 0.0003 0.767052 
5 310 0.1864 0.234 ± 0.0003 0.436176 
6 315 0.0839 0.252 ± 0.0006 0.211428 
7 320 0.0180 0.262 ± 0.0006 0.04716 
   SPF 2.378875 ± 0.90 
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Table: 22Lutein 200 µg/ml 
Sl.no     Wavelength (  nm )      EE * I 
(Normalized)  
Absorbance  
Lutein (200 
µg/ml) 
Mean ± SEM 
SPF value 
 
1 290 0.0150 0.495 ± 0.0006                                 0.07425
2 295 0.0817 0.484 ± 0.0003 0.395428 
3 300 0.2874 0.475 ± 0.0006 1.36515 
4 305 0.3278 0.463 ± 0.0003 1.517714 
5 310 0.1864 0.475 ± 0.0003 0.8854 
6 315 0.0839 0.495 ±0.0006 0.415305 
7 320 0.0180 0.511 ±0.0006 0.09198 
 
 
  SPF 4.745227 ± 1.79 
 
 
The SPF number of lutein 50µg/ml is 1.15 ± 0.43. The SPF number of  lutein 100µg/ml is   
2.38 ± 0.90. The SPF number of  lutein 200µg/ml is  4.75 ± 1.79.         .  
SPF value for sunscreen above 2 isconsidered as having good sunscreen 
activity.Marketed sunscreen lotion having concentration 200µg/ml shows SPF value about 
0.66±0.006. ( Manoj A. Suva., 2014) 
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ANTI-INFLAMMATORY ACTIVITY 
Hydroalcoholic extract of Commelinabenghalensis L. was subjected to Anti-
Inflammatory activity by Membrane stabilization method. 
 
FIGURE:22 PERCENTAGE OF MEMBRANE STABILIZATION BY DICLOFENAC 
SODIUM AND HAECB 
 
 
 
The inhibitory concentration (IC50) of Commelinabenghalensis L. (Leaf) in HRBC 
membrane stabilization study is found to be 69µg/mLin comparison with diclofenac 
sodium57µg/mL. 
 
 
 
 
 
0
5
10
15
20
25
30
35
40
0 10 20 30 40 50
%
M
e
m
b
ra
n
e
 s
ta
b
il
iz
a
ti
o
n
 
Concentration (µg/ml) 
HRBC MEMBRANE STABILIZATION EFFECT 
of Commelina benghalensis L.  
Diclofenac
HAECB
                                                                             RESULTS AND DISCUSSION 
 
DEPT. OF PHARMACOGNOSY, COP, MMC, MADURAI-20 Page 133 
 
 
Table:23 PERCENTAGE OF MEMBRANE STABILIZATION BY DICLOFENAC 
SODIUM AND HAECB 
 
   *Mean of three readings ± SEM 
 
HAECB showed mild anti-inflammatory activity. 
 
 
 
 
 
 
 
S.NO 
Concentration 
(µg/ml) 
Percentage membrane 
stabilization of 
Diclofenac* 
Percentage membrane 
stabilization of 
HAECB* 
1 10 8.14 ± 0.0088 7.7 ± 0.0577 
2 20 22.75 ± 0.0088 9 ± 0.0577 
3 30 25.9 ± 0.0088 23.5 ± 0.1453 
4 40 34.4 ± 0.3333 29.3 ± 0.0882 
 IC50 57 µg/mL 69  µg/mL 
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ANTI-ARTHRITIC ACTIVITY 
Hydroalcoholic extract of Commelinabenghalensis L. was subjected to Anti-Arthritic 
activity by Protein denaturation method. 
 
Figure: 23Effect of HAECB and Diclofenac Sodium on Inhibition of Protein Denaturation 
 
 
The inhibitory concentration (IC50) of Commelinabenghalensis L. (Leaf) in Protein 
denaturation is found to be 17µg/mL in comparison with diclofenac sodium 14µg/mL. 
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Table: 24  Effect Of HAECB and Diclofenac Sodium on Inhibition of  Protein Denaturation 
 
 
   *Mean of three readings ± SEM 
 
HAECB showed moderate anti-arthritic activity. 
 
 
 
 
 
 
 
 
Sl. NO Concentration   in 
µg/ml 
% Inhibition 
 
Diclofenac                            HAECB 
1 10 65.6 ± 0.3464 59.4 ± 0.2309 
2 20 71.9 ± 0.5774 64.1 ± 0.0882 
3 30 78.1 ± 0.0882 73.4 ± 0.2309 
4 40 82.8 ± 0.5774 76.6 ± 0.1732 
 IC50 14  µg/mL 17  µg/mL 
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INVITRO ANTIOXIDANT STUDIES 
Hydroalcoholic extract was subjected to in-vitro antioxidant studies. It includes hydrogen 
peroxide scavenging activity, Reducing power assay, total antioxidant capacity.  
Determination of Hydrogen peroxide scavenging activity of Commelinabenghalensis L. 
(leaf) (HAECB) 
 
Figure: 24 Hydrogen Peroxide Scavenging Effect of Ascorbic Acid 
  
Figure: 25 Hydrogen Peroxide Scavenging Effect of HAECB 
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The inhibitory concentration (IC50) of Commelinabenghalensis L.(Leaf) against hydrogen 
peroxide scavenging effect is found to be 18 µg/mL in comparison with ascorbic acid 7µg/mL. 
Table: 25 Determination of Hydrogen peroxide scavenging activity of 
Commelinabenghalensis L. (leaf) (HAECB) 
 
S.no 
            Concentration 
 
Ascorbic acid     Commelina 
(µg/mL)            benghalensis L.                  
                           (µg/mL) 
Percentage 
inhibition of 
Ascorbic acid 
Percentage inhibition 
of 
Commelinabenghalensis 
L. 
(µg/mL) 
1 5        10 49 ± 0.333 44 ± 0.333 
2 10       20 79 ± 0 54 ± 0 
3 15                         30 89 ± 0 74 ± 0 
                                             IC50 7 µg/mL 18 µg/mL 
 
It requires the double the concentration of ascorbic acid to reduce the free radicals. It 
showed mild anti oxidant effect when compared with ascorbic acid. It requires the double the 
concentration of ascorbic acid to scavenge the free radicals generated. 
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Determination of Reducing power assay of Commelinabenghalensis L. (leaf) 
(HAECB) 
  
                  Figure: 26 Reducing Power Assay of Ascorbic Acid 
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The inhibitory concentration (IC50) of Commelinabenghalensis L.(Leaf) against reducing 
power assay determinedin comparison with ascorbic acid used as a standard. The inhibitory 
concentration (IC50) of Commelina benghalensis L.(Leaf) in reducing power assay is found to be 
12 µg/mL in comparison with ascorbic acid 9µg/mL. 
TABLE: 26Determination of Reducing Power Assay of CommelinaBenghalensis L. (Leaf) 
(HAECB) 
S.no             Concentration 
 
Ascorbic acid     Commelina 
(µg/mL)              benghalensis L. 
                           (µg/mL) 
Percentage 
inhibition of 
Ascorbic acid 
Percentage inhibition 
of 
Commelinabenghalensis 
L. 
(µg/mL) 
1 5        10 60 ± 0.333 72 ± 0.333 
2 10       20 63 ± 0.333 78 ± 0.333 
3 1530 66 ± 0.333 83 ± 0.333 
 20                      79 ± 0.333  
 IC50  9 µg/mL  12 µg/mL 
 
 It showed moderate antioxidant effect when compared with ascorbic acid. 
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Determination of Total antioxidant capacity of Commelinabenghalensis L. 
(leaf) (HAECB) 
 
 
FIGURE: 28 TOTAL ANTIOXIDANT ACTIVITY OF ASCORBIC ACID 
 
FIGURE: 29 TOTAL ANTIOXIDANT ACTIVITY OF HAECB 
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The inhibitory concentration (IC50) of Commelinabenghalensis L.(Leaf) against total 
antioxidant capacity was determined in comparison with ascorbic acid used as a standard. The 
total antioxidant capacity is found to be 40 µg/mL in comparison with ascorbic acid 10 µg/mL. 
Table: 27 Determination of Total Antioxidant Capacity of Commelinabenghalensis L. 
(Leaf) (HAECB) 
S.no Concentration 
 
Ascorbic acid     Commelina 
(µg/ml)                benghalensis L. 
                             (µg/ml) 
Percentage 
inhibition of 
Ascorbic acid 
Percentage inhibition 
of 
Commelinabenghalensis 
L. 
(µg/ml) 
1 5        10 37 ± 0.882 3 ± 0.577 
2 15       20 72 ± 0.577 6 ± 0.577 
3 30  20 ± 0.667 
  40  69 ± 0.577 
 IC50 10 µg/mL 40 µg/mL 
 
Concentration of hydroalcoholic extract of Commelinabenghalensis L. requires 4 times 
the amount of ascorbic acid to reduce the free radicals. It showed mild anti oxidant effect when 
compared with ascorbic acid. It requires the 4 times the concentration of ascorbic acid to 
scavenge the free radicals generated. 
CHAPTER-6 
 
SUMMARY 
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SUMMARY 
Chapter 1  
It consists of introduction of the present thesis. It includes the importance of plant and 
diagnosis, cure & prevent the disease. 
Chapter 2 
 It consists of literature review of the present thesis. It includes ethno claim review, 
phytochemical review, pharmacological review. Ethno claim review such as plant part used for 
various disease. Phytochemical review is used for the presence of active constituents detected 
previously. Pharmacological review helps to identify the activity studied so far. 
 Chapter 3 
 It contains aims and objective of the present thesis. The aim of present research is to 
study the Pharmacognostical, Phytochemical studies includes isolation of lutein and 
Pharmacological evaluation of sun protection factor of isolated lutein, and anti-inflammatory, 
anti-arthritic activity of Commelina benghalensis L. 
Chapter 4 
 It consists materials and methods of the present thesis. It is divided into part A,B,C. 
 Part A includes pharmacognostical studies, macroscopy of Commelina benghalensis L. 
(Leaf), quantitative microscopy,  determination of  physio - chemical constants,  behavioural 
characters of the Commelina benghalensis L. (leaf- crude powder) with different reagents, 
determination of physical parameters of (HAECB), 
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Part B includes phytochemical studies, preliminary phytochemical screening of hydro- 
alcoholic extract of Commelina benghalensis L. (leaf), TLC profile, determination of tannic acid 
equivalent in (HAECB), determination of gallic acid content equivalent in (HAECB), 
determination of rutin equivalent in (HAECB), determination of chlorophyll “a”, chlorophyll 
“b”, total chlorophyll and total carotenoid, UV report and NMR spectrum report of carotenoids 
(lutein). 
  Part C includes pharmacological studies. invitro anti-inflammatory studies, antiarthritic 
studies , sun protection factor studies of isolated lutein, and anti-oxidant study.  
Chapter 5  
 It consist results and discussion of the present research thesis.  It includes the result for 
macroscopy of Commelina benghalensis L.(Leaf), quantitative microscopy, Stomatal  Number - 
(lower epidermis - minimum 39, maximum 48, average 42.6) (upper epidermis - minimum 15, 
maximum 20, average 17.8). Stomatal Index- (lower epidermis - minimum 30.7, maximum 34.5, 
average 32.0) (upper epidermis - minimum 13.8, maximum 20.8, average 17.32).  
Determination of physio – chemical constants, The Physio – chemical constants of 
Commelina benghalensis L. (Leaf – crude powder) was found to be, Loss on drying (0.78 ± 
0.11% w/w), Total Solids (99.22 ± 0.11 % w/w). The powder did not possess any foreign matter, 
bitter principle and volatile oil content. The powder also exhibits Petroleum ether extractive 
value (0.6 ± 0.12% w/w), Ethyl acetate extractive values (1.6 ± 0.12%  w/w), Chloroform 
extractive value (1.7  ± 0.07% w/w), Methanol extractive values (4.4  ± 1.29% w/w), Aqueous 
extractive values (12.13  ± 1.30% w/w), Total ash value (16 % w/w), Water soluble ash value 
(10.5 % w/w), Acid insoluble ash value (1.17 % w/w) 
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Behavioural characters of the Commelina benghalensis L. (Leaf – crude powder) with 
different reagents, determination of physical parameters of (HAECB), Crude powder when 
treated with Water, Con.HCl, Con H2SO4, CH3COOH, Con HCl + Water, Con H2SO4 + Water 
and Aqueous NaOH, Aqueous Fecl3 showed black colour in visible light. Powder treated with 
Con.HNO3 and Con.HNO3 + Water showed yellow colour in visible light. Powder treated with 
CH3COOH + Water showed yellowish brown colour in visible light. Powder when treated with 
Water and Con.HCl showed brown colour in UV 254 nm. Powder treated with Con.H2SO4 
showed dull brown colour in UV 254 nm. Powder treated with Con.HNO3 showed green colour 
in UV 254 nm. Powder when treated with CH3COOOH, Con.HCl + Water, Con.H2SO4 + Water, 
Con.HNO3 + Water, CH3COOH + Water, Aqueous NaOH, Aqueous Fecl3 showed dull green 
colour in UV 254 nm. The powder did not show any characteristic colour change with the 
reagent under UV 366 nm.   
Determination of physical parameters of (HAECB), The physical parameters of hydro 
alcoholic extracts of Commelina benghalensis L. (Leaf) such as refractive index, weight per ml, 
consistency and colour was determined. It was found to be refractive index (1.342 ± 0.002), 
weight per ml (0.882 ± 0.010), dark brown in colour with semisolid consistency. 
The phytochemical screening of the hydroalcoholic extract (70%) of Commelina 
benghalensis L. (Leaf) powder revealed the presence of alkaloids, carbohydrates, sterols, 
saponins, tannins and phenolic compound, flavonoids, protein and free aminoacid, terpenoids, 
mucilage, betacyanin, quinone, phlobatannins, carotenoids. It shows the absence of 
anthraquinone glycosides, cardiac glycoside, fixed oil, anthocyanin, lecoanthocyanin, emodin, 
gum, resins, volatile oil. The aqueous extract of Commelina benghalensis L. (Leaf) powder 
revealed the presence of alkaloids, carbohydrates, sterols, saponins, tannins and phenolic 
compound, flavonoids, protein and free aminoacid, mucilage, emodin, quinone, phlobatannins, 
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carotenoids. It shows the absence of anthraquinone glycosides, cardiac glycoside, terpenoids, 
fixed oil, betacyanin, gum, anthocyanin, lecoanthocyanin, resins, volatile oil. 
TLC profile  
Thinlayer chromatography of the hydroalcoholic extract of Commelina benghalensis L. 
(Leaf) showed the Rf value 0.25(Gallic acid standard) 0.25, 0.90 (HAECB) may indicate the 
presence of phenolic compounds the solvent system used in Acetic acid : Chloroform (1:9). Rf 
value 0.72 (Gallic acid standard), 0.73, 0.90 (HAECB) may indicate the presence of phenolic 
compounds the solvent system used in Ethyl acetate : Benzene (9:11). Rf value 0.46 (Rutin 
standard) 0.71 (HAECB), may indicate the presence of flavonoids the solvent system used in 
Chloroform : Ethyl Acetate (60:40). Rf value 0.42 (Rutin standard), 0.45,0.93,0.97 (HAECB) 
may indicate the presence of flavonoids, flavones, flavonols the solvent system used in Ethyl 
Acetate : Formic Acid : Glacial Acetic Acid : Water (100:11:11:26). 
Determination of gallic acid content equivalent in (HAECB), in terms of (GAE) was 
found to be 112 mg/g. Determination of tannic acid equivalent in (HAECB), in terms of (TAE) 
was found to be 198 mg/g. Determination of rutin equivalent in (HAECB), in terms of (RE) was 
found to be 989mg/g.   
Determination of Chlorophyll “a”, Chlorophyll “b”, Total chlorophyll and Total 
carotenoid content in fresh leaves of Commelina benghalensis L.  It was found to be Chlorophyll 
“a” (0.00311 mg/gm), Chlorophyll “b” (0.017506 mg/gm), Total chlorophyll (0.052588 mg/gm) 
and Total carotenoid (0.06878 mg/gm). 
UV report of carotenoids (lutein) 
Lutein and Chlorophyll, Aliquot of crude extract was transferred to cuvette and was 
scanned under UV range from 300 – 700 nm in the UV – Visible spectrophotometer to check the 
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presence of chlorophyll and lutein. It shows the absorbance maxima at 665, 466, 412 nm. It 
indicates the presence of chlorophyll (665 nm) and lutein (466, 412 nm)  
Lutein, the isolated compound was dissolved in diethyl ether and transferred to cuvette 
and was scanned under UV range from 300 – 700 nm in the UV – Visible spectrophotometer. 
The isolated compound lutein showed absorbance maxima at 470 and 444 nm indicates the 
presence of lutein. 
NMR studies 
 The Isolated compound was dissolved in Duterated chloroform (CDCL3) and it showed 
the chemical shift value of 1H NMR 
1H NMR: (300 MHz, CDCl3) δH 0.78(s, 10H), 0.94 - 1.00 (bd, 2H), 1.12 - 1.35 (bm, 21H), 1.53-
1.60 (bd, 3H), 1.81-1.90 (bd, 8H), 3.38-3.45 (m, 2H), 4.73 (s, 1H). 
The Isolated compound was dissolved in Duterated chloroform (CDCL3) and it showed 
the chemical shift value for 13C NMR. 
13C NMR: (75 MHz, CDCl3); δC 15.3, 19.7, 19.9, 22.6, 22.7, 24.8, 25.2, 28.0, 29.7, 31.9, 32.7, 
32.8, 36.7, 37.3, 37.5, 38.4, 65.9, 130.3. 
GC-MS studies  
 Some of the peaks were relevant with molecular weight in the GC-MS profile 
(Figure: 21-21.24), identified the presence of certain linkages of lutein. Hence the derived 
Ultraviolet spectrum (Table 13&14), Nuclear Magnatic Resonance (1H NMR, 13C NMR) 
spectrum (Table15,16&17) and GC-MS profile (Table:18) confirmed the molecular weight of 
lutein and also supports the additional research work indicating the chemical structure of lutein 
from the leaf powder. 
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Determination of Sun protection factor 
The SPF number of lutein 50µg/ml is found to be 1.15 ± 0.43. The SPF number of lutein 
100µg/ml is found to be 2.38 ± 0.90. The SPF number of lutein 200µg/ml is found to be 4.75 ± 
1.79.         .  
SPF value for sunscreen above 2 is considered as having good sunscreen activity. 
Marketed sunscreen lotion having concentration 200 µg/ml shows SPF value about 0.66±0.006.  
( Manoj A. Suva., 2014) 
 
 
Invitro membrane stabilization study 
 Lysosomes are intracellular particles which contain most of the lytic and digestive 
enzymes of the tissue. The rupture of the lysosomes results in injury or death to surrounding 
tissues and also acute inflammation. The membranes of lysosomes and erythrocytes are 
destroyed by similar agents; hence a test was developed to measure the ability of compounds to 
stabilize erythrocyte membrane to heat hemolysis. RBC when exposed to various injurious 
substances such as methyl salicylate, phenyl hydrazine, and hypotonic medium or over heat will 
cause lysis of membrane accompanied by haemolysis and oxidation of haemoglobin. RBC 
membranes are easily susceptible to free radical mediated lipid peroxidation by breakdown of 
biomolecules. Due to it has rich source of iron and high oxygen partial pressure. RBC 
membranes are similar to lysosomal cells. All NSAIDs inhibited hemolysis while other type of 
compounds had no effect. Hence prevention of hypotonic and heat mediated RBC membrane 
lysis taken as measure of anti-inflammatory activity of drugs. 
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 A study has reported that the flavonoids exert membrane stabilizing effect on 
lysosomes both invitro and invivo in experimental animals. Another report has suggested that 
tannins and saponins have the ability to bind cations and other biomolecules and are able to 
stabilize the erythrocyte membrane. HAECB extract is highly potent on human erythrocyte and 
thus adequately protecting it against heat and hypotonicity induced lysis. The inhibitory 
concentration (IC50) of Commelina benghalensis L. (Leaf) in HRBC membrane stabilization 
study is found to be 69µg/ml in comparison with diclofenac sodium 57µg/ml. It showed mild 
anti-inflammatory activity. 
 The phytochemical analysis showed that the HRBC has flavonoids and tannins. Hence 
the HRBC membrane stabilizing capacity may be due to the presence of the above mentioned 
constituents which will prevent the oxidation of haemoglobin and also due to its antioxidant 
property. 
Invitro antiarthritic activity by protein denaturation method 
 The principle involved is the inhibition of protein denaturation. Denaturation of protein 
was found to be one of the causes of rheumatoid arthritis. In rheumatoid arthritis, the production 
of autoantigen may be due to protein denaturation which involves the alteration of electrostatic 
hydrogen, hydrophobic and disulphide bonding. 
 The protein used in this study is bovine serum albumin. Denaturation of protein is 
carried out by heating. The aim of this activity is to inhibit denaturation and to exhibit protective 
effect against rheumatoid arthritis. The inhibitory concentration (IC50) of Commelina 
benghalensis L. (Leaf) in Protein denaturation is found to be 17µg/ml in comparison with 
diclofenac sodium 14µg/ml. It showed moderate anti-arthritic activity. The inhibition of protein 
denaturation by HAECB may be due to the presence of phenolic compounds, flavonoids and 
tannins.  
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Anti-oxidant study 
 It includes four methods. Determination of scavenging activity against hydrogen 
peroxide, Reducing power assay, determination of total antioxidant activity. The inhibitory 
concentration (IC50) of Commelina benghalensis L. (leaf) against hydrogen peroxide 
scavenging effect is found to be 18µg/ml in comparison with ascorbic acid 7µg/ml. The 
inhibitory concentration (IC50) of Commelina benghalensis L. (leaf) against reducing power 
assay determined in comparison with ascorbic acid used as a standard. The inhibitory 
concentration (IC50) of Commelina benghalensis L. (leaf) in reducing power assay is 
12µg/mL in comparison with ascorbic acid 9µg/mL. The inhibitory concentration (IC50) of 
Commelina benghalensis L. (leaf) against total antioxidant capacity was determined in 
comparison with ascorbic acid used as a standard. The total antioxidant capacity is found to 
be 40µg/ml in comparison with ascorbic acid 10µg/ml. 
Chapter 6 It consists of summary of the present thesis.  
Chapter 7 It includes the conclusion.  
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CONCLUSION 
➢ The present investigation draws the following conclusion (succeeding) inference. 
➢ Pharmacognostical parameters for the leaves of Commelina benghalensis L. Hexacytic 
stomato and raphides are  the diagnostic features of Commelina benghalensis L. 
➢ The derived parameters would help to fix or draw the monographical standards. 
➢ Quantitative estimation helps to identify the gallic acid, tannic acid, and flavonoids 
equivalents present in the hydroalcoholic extract of Commelina benghalensis L.    
➢ Chlorophyll “a”, Chlorophyll “b”, Total chlorophyll and Total carotenoid content in fresh 
leaves of Commelina benghalensis L. were determined. 
➢ TLC studies recorded the presence of flavonoids, flavones, flavonols and phenolic 
compounds. 
➢ The phytochemical screening of the hydroalcoholic extract (70%) of Commelina 
benghalensis L. (Leaf) powder revealed the presence of alkaloids, carbohydrates, sterols, 
saponins, tannins and phenolic compound, flavonoids, protein and free aminoacid, 
terpenoids, mucilage, betacyanin, quinone, phlobatannins, carotenoids. The aqueous 
extract of Commelina benghalensis L. (Leaf) powder revealed the presence of alkaloids, 
carbohydrates, sterols, saponins, tannins and phenolic compound, flavonoids, protein and 
free aminoacid, mucilage, emodin, quinone, phlobatannins, carotenoids. 
➢ Isolation of carotenoids such as Lutein was confirmed by UV, NMR (1H NMR,13C 
NMR), and GC-MS spectrum. 
➢ Pharmacological screening potentiates the biological invitro anti-inflammatory effect, 
invitro anti-arthritic effect, invitro sun protection effect of isolated lutein, and invitro-
antioxidant effect. 
➢ At the site of inflammation, HAECB may possibly inhibit the release of lysosomal 
content of neutrophils (bactericidal enzymes and proteinases) which upon extracellular 
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release cause further tissue inflammation and damage (Chou, 1997). In the present study, 
results indicate that the HAECB possesses significant anti-inflammatory properties which 
may be due to the strong occurrence of polyphenolic compounds such as flavonoids, 
tannins and phenols.  
➢  HAECB showed significant antiarthritic activity by inhibition of protein denaturation. 
Rheumatoid arthritis (RA) being a common inflammatory disease affects about 1% of the 
adult population worldwide. It occurs in immunogenetically predisposed individuals. 
Protein denaturation was found to be one of the causes of RA. HAECB has shown 
significant anti-arthritic activity and the phenolic constituent may be responsible for this 
activity. 
➢ Further investigation may be carried out for the bio-active fraction for its potential 
pharmacological effects. 
➢ Future research studies may be extended to isolate other phyto-constituents present in this 
plant. 
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